Unchanged

Summary of findings {#CD011432-sec1-0001}
===================

Summary of findings for the main comparisonTuberculosis outreach screening versus no intervention**Tuberculosis outreach screening (with or without health promotion) to encourage presumptive tuberculosis patients to attend health servicesPatient or population:** all age groups\
**Settings:** countries with moderate or high tuberculosis prevalence (\> 10 tuberculosis cases per 100,000 population per year)\
**Intervention:** tuberculosis outreach screening with and without health promotion activities\
**Comparison:** no screening\
**Trial design:** cluster‐RCTs only (non‐randomized studies are commented on in the footnotes)**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)Number of participants (studies)Certainty of the evidence (GRADE)CommentsAssumed riskCorresponding riskNo interventionTuberculosis outreach screening ± health promotion**Tuberculosis cases detected (microbiologically confirmed)90 per 100,000112 per 100,000\
(77 to 161)RR 1.24 (0.86 to 1.79)163,043 participants\
in 297 clusters\
(4 studies)low^1,2,3,4^\
due to imprecision and inconsistencyScreening with health promotion may increase the number of microbiologically confirmed people with tuberculosis.Default within first 2 months16 per 10012 per 100\
(8 to 15)RR 0.67\
(0.47 to 0.96)849 patients\
(3 cluster‐RCTs)low^1,2,5^\
due to imprecisionScreening with health promotion may reduce default prior to and at the first 2 months of tuberculosis treatment.Treatment success78 per 10083 per 100\
(78 to 90)RR 1.07\
(1.00 to 1.15)849 patients\
(3 cluster‐RCTs)low^1,6,7^\
due to imprecision and indirectnessScreening with health promotion may have little or no effect on treatment success.Treatment failure1.3 per 1002.0 per 100\
(0.3 to 6.4)RR 1.57\
(0.50 to 4.92)849 patients\
(3 cluster‐RCTs)very low^1,2,5,8^\
due to imprecision and indirectnessWe do not know if screening with health promotion influences treatment failure.Tuberculosis mortality3 per 1003 per 100\
(1.3 to 6.75)RR 0.99\
(0.43 to 2.25)849 patients\
(3 cluster‐RCTs)low^1,2,3,5^\
due to imprecisionScreening with health promotion may have little or no effect on mortality.Long‐term tuberculosis prevalence773 per 100,000881 per 100,000\
(502 to 1546)RR 1.14\
(0.65 to 2.00)556,836 participants\
in 12 clusters\
(1 cluster‐RCT)very low^1,2,7,8^\
due to imprecision and indirectnessWe do not know if screening with health promotion influences treatment failure.The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). Abbreviations: CI: confidence interval; RCT: randomized controlled trial; RR: risk ratioGRADE Working Group grades of evidence **High certainty:** further research is very unlikely to change our confidence in the estimate of effect. **Moderate certainty:** further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low certainty:** further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low certainty:** We are very uncertain about the estimate.[^2]

Summary of findings 2Health promotion activities versus no intervention**Health promotion activities to encourage people with symptoms of tuberculosis to attend health servicesPatient or population:** all age groups\
**Settings:** areas with moderate or high tuberculosis prevalence\
**Intervention:** health promotion activities alone\
**Comparison:** no intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)Number of participants (studies)Certainty of the evidence (GRADE)CommentsAssumed riskCorresponding riskNo interventionHealth promotion**Long‐term tuberculosis prevalence\
(assessed at 4 years)773 per 100,0001012 per 100,000\
(580 to 1778)RR 1.31\
(0.75 to 2.30405,788 in 12 clusters\
(1 cluster‐RCT)very low^1,2,3,4^We do not know if health promotion reduces long‐term tuberculosis prevalence.Treatment success------------(0 studies)---Tuberculosis mortality------------(0 studies)---Long‐term tuberculosis prevalence------------(0 studies)---\*The basis for the **assumed risk** (for example, the median control group risk across studies) is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). Abbreviations: CI: confidence interval; RCT: randomized controlled trial; RR: risk ratioGRADE Working Group grades of evidence **High certainty:** further research is very unlikely to change our confidence in the estimate of effect. **Moderate certainty:** further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low certainty:** further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low certainty:** We are very uncertain about the estimate.[^3]

Summary of findings 3Training interventions compared to no intervention**Health staff training in tuberculosis diagnosisPatient or population:** all age groups\
**Settings:** areas with moderate or high tuberculosis prevalence\
**Intervention:** health staff training activities\
**Comparison:** no intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)Number of participants (studies)Certainty of the evidence (GRADE)CommentsAssumed riskCorresponding riskNo interventionHealth promotion**Tuberculosis cases detected (microbiologically confirmed)3360 per\
100,0005644 per\
100,000\
(3461 to 9139)RR 1.68\
(1.03 to 2.72)1999 participants\
in 2 clusters\
(1 study)low^1,2,3,4^Training of health staff may increase the number of microbiologically confirmed people with tuberculosis.Treatment success---------(0 studies)------Tuberculosis mortality---------(0 studies)------Long‐term tuberculosis prevalence---------(0 studies)------\*The basis for the **assumed risk** (for example, the median control group risk across studies) is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). Abbreviations: CI: confidence interval; RR: risk ratio.GRADE Working Group grades of evidence **High certainty:** further research is very unlikely to change our confidence in the estimate of effect. **Moderate certainty:** further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low certainty:** further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low certainty:** We are very uncertain about the estimate.[^4]

Summary of findings 4Outreach tuberculosis screening versus health promotion**Outreach tuberculosis screening versus health promotionPatient or population:** adults\
**Settings:** areas with moderate or high tuberculosis prevalence\
**Intervention 1:** mobile clinic situated in each cluster for 5 days every 6 months with associated leafleting and loudspeaker\
**Intervention 2:** house‐to‐house screening every 6 months**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)Number of participants (studies)Certainty of the evidence (GRADE)CommentsAssumed riskCorresponding riskMobile clinicHouse‐to‐house**Tuberculosis cases detected (microbiologically confirmed)250 per 100,000406 per 100,000\
(317 to 578)RR 1.71\
(1.27 to 2.31)110,162\
(1 study)very low^1,2,3,4^We do not know if outreach tuberculosis screening activities increase the number of microbiologically confirmed people with tuberculosis.Treatment success---------(0 studies)------Tuberculosis mortality---------(0 studies)------Long‐term tuberculosis prevalence---------(0 studies)------\*The basis for the **assumed risk** (for example, the median control group risk across studies) is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). Abbreviations: CI: confidence interval; RR: risk ratio.GRADE Working Group grades of evidence **High certainty:** further research is very unlikely to change our confidence in the estimate of effect. **Moderate certainty:** further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low certainty:** further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low certainty:** We are very uncertain about the estimate.[^5]

Summary of findings 5Outreach clinic versus house‐to‐house screening**Outreach clinic compared with house‐to‐house screening for presumptive tuberculosis patients to test for tuberculosisPatient or population:** adults\
**Settings:** high tuberculosis burden setting\
**Intervention:** outreach clinic\
**Comparison:** house‐to‐house**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)Number of participants (studies)Certainty of the evidence (GRADE)CommentsAssumed riskCorresponding riskHouse‐to‐houseOutreach clinic**Tuberculosis cases detected (microbiologically confirmed)238 per 1000352 per 1000 (264 to 469)RR 1.48 (1.11 to 1.97)405,819 participants in\
46 clusters\
(1 study)very low^1,2,3,4^We do not know if outreach clinic activities increase tuberculosis cases detected.Treatment success---------(0 studies)------Tuberculosis mortality---------(0 studies)------Long‐term tuberculosis prevalence---------(0 studies)------\*The basis for the **assumed risk** (for example, the median control group risk across studies) is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). Abbreviations: CI: confidence interval; RR: risk ratio.GRADE Working Group grades of evidence **High certainty:** further research is very unlikely to change our confidence in the estimate of effect. **Moderate certainty:** further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low certainty:** further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low certainty:** We are very uncertain about the estimate.[^6]

Background {#CD011432-sec1-0002}
==========

Description of the condition {#CD011432-sec2-0001}
----------------------------

Tuberculosis is caused by infection with the bacterium *Mycobacterium tuberculosis.* In 2015, the World Health Organization (WHO) reported 10.4 million new cases globally, causing 1.8 million deaths ([@CD011432-bbs2-0102]). Africa and Asia are most heavily affected. India, Indonesia, and China contribute over 40% of the world\'s tuberculosis cases, and populations in some African countries have the highest rates per capita ([@CD011432-bbs2-0102]).

Pulmonary tuberculosis (infection of the lungs) is the most common form of tuberculosis, as well as the most infectious, as transmission occurs from person‐to‐person via inhalation of respiratory droplets expelled when coughing or sneezing ([@CD011432-bbs2-0083]). However, most people who are infected with *M. tuberculosis* initially develop latent tuberculosis, where the infection is contained by the immune system and the person remains well ([@CD011432-bbs2-0094]). Active tuberculosis, with the development of symptoms, can occur at any time and is strongly associated with immune system impairment due to illnesses such as HIV, malnutrition, and diabetes ([@CD011432-bbs2-0090]).

The gold‐standard test for pulmonary tuberculosis is sputum culture, but as this can take up to eight weeks due to the slow growth of the bacterium, treatment is usually started based on other test results ([@CD011432-bbs2-0092]). Sputum smear microscopy and Xpert MTB/RIF (a DNA amplification test) are the most commonly used initial tests and may be combined with a chest X‐ray ([@CD011432-bbs2-0095]; [@CD011432-bbs2-0098]). Treatment of drug‐sensitive pulmonary tuberculosis requires patients to take a combination of medicines for six to nine months ([@CD011432-bbs2-0100]), while drug‐resistant forms typically require much longer courses.

Guidelines in high‐burden countries advise health workers to consider pulmonary tuberculosis in all people with a cough lasting more than two weeks ([@CD011432-bbs2-0100]). However, most people diagnosed with tuberculosis have been coughing for much longer than this by the time they are tested ([@CD011432-bbs2-0082]; [@CD011432-bbs2-0088]). People may delay seeking care due to the stigma associated with tuberculosis, uncertainty about the severity of their illness, the distance to health services, the affordability of health services, or poor perceptions of the local quality of care ([@CD011432-bbs2-0091]). Similarly, health workers may delay diagnosis due to a lack of awareness or training in tuberculosis diagnosis, or the unavailability of appropriate tests ([@CD011432-bbs2-0097]).

Description of the intervention {#CD011432-sec2-0002}
-------------------------------

Pulmonary tuberculosis is usually diagnosed when symptomatic individuals present to healthcare services. This is termed \'passive case detection\', as the health system doesn\'t play a role in the health‐seeking behaviour of the individual. Concerns about delayed diagnosis increasing transmission, and a growing desire to tackle the global epidemic head‐on have led to the promotion of more \'active\' approaches to seek out early or undiagnosed tuberculosis cases amongst communities ([@CD011432-bbs2-0099]).

Two terms are now used commonly in the literature: \'active case‐finding\', which is typically interpreted as systematic screening of populations, and \'enhanced case‐finding\', which is harder to define but typically involves a lower degree of effort ([@CD011432-bbs2-0084]). The interventions included under these terms are highly variable, and often multifaceted, containing elements that reduce multiple barriers to accessing care. For example, programmes that systematically screen households for tuberculosis will typically improve tuberculosis diagnostic skills among health workers (through training), reduce the financial costs of attending health care (by providing the initial screening test at the patient\'s home), as well as reduce barriers related to patient awareness of their illness and stigma related to the disease. As the barriers to accessing a tuberculosis diagnosis vary considerably between settings, successful programmes will need to both be aware of the local problems and be designed specifically to overcome them.

For the purposes of this Cochrane Review, we considered any intervention aimed at increasing confirmed tuberculosis cases by providing either improved diagnostic services or health promotion activities at primary health care or the community level.

How the intervention might work {#CD011432-sec2-0003}
-------------------------------

Community‐based interventions may initially increase tuberculosis case detection by: 1) identifying people with early tuberculosis who are not yet sufficiently unwell to seek care; or 2) identifying people with advanced tuberculosis who would not have presented to health services of their own accord ([Figure 1](#CD011432-fig-0001){ref-type="fig"}).Figure 1Logic model showing the additional cases that would never present passively and long‐term impact on lowering tuberculosis prevalence and incidence.

People who present late to health services, when the disease is severe, tend to have poorer health outcomes ([@CD011432-bbs2-0085]). Decreasing the time to diagnosis could therefore translate into improved health outcomes for people with tuberculosis. These may be disease‐related outcomes, such as cure or death, but could also be socioeconomic outcomes, such as reduced time off work or reduced loss of earnings. Although diagnosing patients early could reduce transmission, there are also concerns that diagnosing people early may lead to higher levels of default from treatment, with subsequent increased spread of resistance.

Although the aim of these interventions is to increase tuberculosis case detection in the short term, the long‐term aim is a reduction in community transmission of tuberculosis, and a consequent fall in tuberculosis incidence and case detection ([@CD011432-bbs2-0084]).

Why it is important to do this review {#CD011432-sec2-0004}
-------------------------------------

Early diagnosis is one of the key components of the WHO End TB Strategy published in 2015 ([@CD011432-bbs2-0101]). It is therefore important to know which interventions work, and under what circumstances.

Objectives {#CD011432-sec1-0003}
==========

To evaluate the effectiveness of different strategies to increase tuberculosis case detection through improved access (geographical, financial, educational) to tuberculosis diagnosis at primary healthcare or community‐level services.

Methods {#CD011432-sec1-0004}
=======

Criteria for considering studies for this review {#CD011432-sec2-0005}
------------------------------------------------

### Types of studies {#CD011432-sec3-0001}

Randomized controlled trials (RCTs) for which the unit of randomization is the individual or cluster, and non‐randomized studies with parallel control groups.

### Types of participants {#CD011432-sec3-0002}

People living in areas with moderate to high tuberculosis prevalence (tuberculosis notification rate of greater than 10 tuberculosis cases per 100,000 population per year).

### Types of interventions {#CD011432-sec3-0003}

#### Intervention {#CD011432-sec4-0001}

Any intervention that aims to improve access to a tuberculosis diagnosis by providing diagnostic services at primary health care or community level. This included educational or health promotion activities, and outreach services using formal and informal health staff through clinics, mobile clinics, and house‐to‐house screening.

#### Control {#CD011432-sec4-0002}

No intervention (standard care) or an alternative intervention for improving access to a tuberculosis diagnosis.

### Types of outcome measures {#CD011432-sec3-0004}

#### Primary outcomes {#CD011432-sec4-0003}

Tuberculosis cases detected (microbiologically confirmed) refers to tuberculosis patients with a positive result of either acid‐fast bacilli (AFB) sputum smear microscopy or GeneXpert MTB/RIF and/or mycobacterial culture (solid or liquid culture).

#### Secondary outcomes {#CD011432-sec4-0004}

Tuberculosis cases starting treatment are all forms tuberculosis patients (either microbiologically confirmed or not) who are started on tuberculosis treatment as reported by individual study.Time to diagnosis refers to time the presumptive tuberculosis patient presents at the health facility until the tuberculosis diagnosis is made.False‐positive results with the initial tuberculosis screening test refers to a positive test result and the individual is erroneously classified as positive for tuberculosis due to imperfect testing methods or procedures.Default within the first two months is classified as early default (prior to commencing tuberculosis treatment or during the intensive phase of treatment).Treatment completion refers to a tuberculosis patient who completed treatment without evidence of failure BUT there is no record to show that sputum smear or culture results in the last month of treatment and on at least one previous occasion are negative, either because they were not done or because results were not available.Tuberculosis cured refers to pulmonary tuberculosis patient who was initially microbiologically confirmed at the beginning of treatment and who had either a negative sputum smear or culture result at the last month of treatment and on at least one previous occasion.Tuberculosis mortality refers to tuberculosis patients who die for any reason before starting or during the course of tuberculosis treatment.Population tuberculosis mortality refers to any cause of death at the population level during the active case‐finding implementation.Programme cost refers to the cost per diagnosed case of tuberculosis.Long‐term tuberculosis prevalence refers to the reduction in tuberculosis prevalence (either microbiologically confirmed or not) in a study population.

Search methods for identification of studies {#CD011432-sec2-0006}
--------------------------------------------

We identified all relevant studies regardless of language or publication status (published, unpublished, in press, and ongoing).

### Electronic searches {#CD011432-sec3-0005}

We searched the following databases: the Cochrane Infectious Disease Group Specialized Register; the Cochrane Central Register of Controlled Trials (CENTRAL, published in the Cochrane Library, Issue 12, 2016); MEDLINE (PubMed, 1966 to 19 December 2016); Embase (OVID, 1980 to 19 December 2016); Science Citation Index Expanded (SCI‐EXPANDED) and Social Sciences Citation Index (SSCI; Web of Science, 1900 to 19 December 2016); BIOSIS Previews (Web of Science, 1926 to 19 December 2016); and Scopus (1970 to 19 December 2016), using the search terms detailed in [Appendix 1](Appendix 1). We also searched the metaRegister of Controlled Trials (mRCT), the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) ([www.who.int/trialsearch](www.who.int/trialsearch)), and ClinicalTrials.gov ([clinicaltrials.gov/](clinicaltrials.gov/)) (all accessed on 19 December 2016), using \'tuberculosis\' and \'case detection\' or \'case finding\' or \'active screening\' as search terms.

### Searching other resources {#CD011432-sec3-0006}

We checked the reference lists of all studies identified by the above methods for other potentially relevant studies.

Data collection and analysis {#CD011432-sec2-0007}
----------------------------

### Selection of studies {#CD011432-sec3-0007}

Two review authors (FM and AM) each independently screened all the citations and abstracts to identify potential eligible studies using a study selection form. We obtained the full reports of potentially eligible studies. FM and AM assessed these for inclusion in the review using a predesigned eligibility form based on the inclusion criteria. Any discrepancies were resolved through discussion or, if required, by consulting a third review author (RD, DS, or LC). Where necessary we contacted the study authors for clarification of study methods. We listed the reasons for excluding studies in the \'Characteristics of excluded studies\' table.

### Data extraction and management {#CD011432-sec3-0008}

Two review authors (FM and AM) independently extracted data from the studies using a tailored data extraction form. Any differences in data extraction were resolved through discussion or, if necessary, by consulting a third review author (DS). We extracted the following study information.

Study details: start and end dates, study location, study design, funding, tuberculosis prevalence (as stated by the study authors).Participant details: who was recruited for tuberculosis diagnostic testing? Where were they recruited? What were the eligibility criteria for a person to have a tuberculosis test?Details of the intervention: what was the initial screening test? What was the diagnostic test? Who conducted the screening? What training did they have? How long were they trained for? What were they trained to do? How were they supervised? Who trained them?Details of any co‐interventions: were there any additional health promotion activities? Was tuberculosis testing free? Were there any financial/material incentives/enablers?Details of the control: what diagnostic services were available to the control groups? What were the local barriers to care? Distance to health services? Cost of attending health facilities?

For dichotomous outcomes (for example, additional tuberculosis cases starting treatment), we extracted the number experiencing the event (numerator) and the total number of people diagnosed with tuberculosis (denominator). For continuous outcomes, we extracted the mean, the standard deviation, and the number of people observed.

#### Cluster‐RCTs {#CD011432-sec4-0005}

For cluster‐RCTs, we recorded the number of clusters, the average size of the clusters, and the method used to adjust for clustering. If the trial authors adjusted for clustering appropriately, we extracted the cluster‐adjusted measure of effect and a measure of variance. For dichotomous outcomes, we extracted the number of participants experiencing the event and the number randomized to each group if the authors did not adjust for clustering. For continuous outcomes, we extracted the summary effect (mean or median) and the measure of variance (standard deviation or range). We extracted the adjusted effect estimate and the standard error for studies that had adjusted for clustering.

#### Non‐RCTs {#CD011432-sec4-0006}

For non‐RCTs, we extracted details of any method used to control confounding, the chosen confounder variables, any reported treatment effects adjusted for one or more baseline characteristics, or any other treatment effect estimate that took confounding into account, for example the overall treatment effects estimate obtained by combining treatment effects from different strata of a study, or an estimate that allows for matching. We contacted the authors for unclear or missing data.

After data extraction, FM entered the data into Review Manager 5 (RevMan 5) ([@CD011432-bbs2-0093]).

### Assessment of risk of bias in included studies {#CD011432-sec3-0009}

Two review authors (FM and AM) independently assessed the risk of bias of each included study using the Cochrane \'Risk of bias\' tool ([@CD011432-bbs2-0093]), and discussed any differences of opinion. In the case of missing or unclear information, we contacted the trial authors for clarification. Review authors who had been involved in any of the included trials were excluded from the \'Risk of bias\' assessment,

The Cochrane approach assesses risk of bias across six domains: sequence generation and allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessors (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and other potential biases. For each domain, we recorded the methods used by the study authors to reduce the risk of bias and assigned a judgement of \'low risk of bias\', \'high risk of bias\', or \'unclear\'.

For cluster‐RCTs, we also considered recruitment bias, baseline imbalance in the appraisal of selection bias, loss of clusters in the appraisal of attrition bias, incorrect analysis, comparability with RCTs, and further considered the risk of contamination bias (where people living in the control areas also benefit from the intervention).

Similarly, for non‐RCTs we used the Risk of Bias In Non‐randomized Studies ‐ of Interventions (ROBINS‐I) to assess the risk of bias for non‐randomized trials ([@CD011432-bbs2-0096]). We considered the seven bias domains grouped into pre‐intervention (bias due to confounding and selection of participants into study), at intervention (bias in classification of interventions), and post‐intervention (bias due to deviations from intended interventions, missing data, measurement of outcomes, and selection of the reported results).

We summarized the results for the assessment of risk of bias using the \'Risk of bias\' summary and the \'Risk of bias\' graph in addition to the \'Risk of bias\' tables.

### Measures of treatment effect {#CD011432-sec3-0010}

For dichotomous data, we used risk ratios as the primary measure of effect. Where study authors have presented data as odds ratios we recalculated the effect. Count data are expressed as rate ratios. For continuous data, we compared arithmetic means using mean differences. We presented all measures with 95% confidence intervals (CIs). Medians and ranges are reported in table format only.

### Unit of analysis issues {#CD011432-sec3-0011}

Where cluster‐RCTs have not adjusted their results for the effect of the cluster design, we adjusted the sample sizes using the methods described in Section 16.3.4 or 16.3.6 of the *Cochrane Handbook for Systematic Reviews of Interventions* ([@CD011432-bbs2-0086]), employing an estimate of the intracluster correlation coefficient (ICC). Where possible, we derived the ICC from the trial itself, or from a similar trial. If an appropriate ICC was not available, we conducted sensitivity analyses to investigate the potential effect of clustering by imputing a range of values of ICC.

When a multi‐arm study contributed multiple comparisons to a particular meta‐analysis, we either combined treatment groups or split the \'shared\' group as appropriate to avoid double counting.

### Dealing with missing data {#CD011432-sec3-0012}

We applied no imputation for missing data. We attempted to contact trial authors to obtain missing or unclear data.

### Assessment of heterogeneity {#CD011432-sec3-0013}

We assessed for statistical heterogeneity between trials by visually inspecting the forest plots to detect overlapping CIs, and applying the Chi² test and I² statistic. We considered a Chi² test P value less than 0.10 as statistically significant. An I² statistic value of 0% to 30% might not be important; 30% to 60% may represent moderate heterogeneity; and more than 60% may indicate substantial or considerable heterogeneity.

### Assessment of reporting biases {#CD011432-sec3-0014}

We planned to assess the likelihood of reporting bias using funnel plots, but there were too few studies.

### Data synthesis {#CD011432-sec3-0015}

We analysed the data using RevMan 5 ([@CD011432-bbs2-0093]). The primary analysis was stratified by study design, and we did not perform meta‐analysis across different trial designs.

We also stratified outcomes by the time point of outcome measurement. Where appropriate, we grouped similar time points together and performed a meta‐analysis (for example, tuberculosis case detection at six to 12 months). When interpreting data at different time points, we kept in mind that the desired outcome of the intervention may change with time. For example, a successful intervention may increase tuberculosis case detection in the short term, but if it influences transmission it may result in a fall in tuberculosis case detection in the long term.

We tabulated results from cluster‐RCTs that could be adjusted for clustering. We used a random‐effects model in the presence of moderate statistical heterogeneity and a fixed‐effect model in the absence of heterogeneity.

### Subgroup analysis and investigation of heterogeneity {#CD011432-sec3-0016}

We investigated potential causes of heterogeneity by performing subgroup analyses by tuberculosis prevalence.

### Sensitivity analysis {#CD011432-sec3-0017}

We planned to perform sensitivity analyses to evaluate the robustness of the results to the risk of bias components, but there were too few studies to make this meaningful.

Results {#CD011432-sec1-0005}
=======

Description of studies {#CD011432-sec2-0008}
----------------------

### Results of the search {#CD011432-sec3-0018}

The study flow diagram is shown in [Figure 2](#CD011432-fig-0002){ref-type="fig"}. The initial searches identified 1646 studies, of which 81 were deemed potentially relevant to this review after the initial abstract screening.Figure 2Study flow diagram.

### Included studies {#CD011432-sec3-0019}

We included 17 studies: nine cluster‐randomized trials ([@CD011432-bbs2-0001]; [@CD011432-bbs2-0002]; [@CD011432-bbs2-0003]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0005]; [@CD011432-bbs2-0010]; [@CD011432-bbs2-0015]; [@CD011432-bbs2-0016]), one individual randomized trial ([@CD011432-bbs2-0012]), and seven non‐RCTs ([@CD011432-bbs2-0006]; [@CD011432-bbs2-0007]; [@CD011432-bbs2-0008]; [@CD011432-bbs2-0009]; [@CD011432-bbs2-0013]; [@CD011432-bbs2-0014]; [@CD011432-bbs2-0017]).

Nine studies were conducted in sub‐Saharan Africa (Ethiopia, Nigeria, South Africa, Zambia, and Zimbabwe), six in Asia (Bangladesh, Cambodia, India, Nepal, and Pakistan), and two in South America (Brazil and Colombia).

Most of the studies evaluated interventions with multiple components. In 10 studies health workers actively looked for tuberculosis cases outside of conventional health facilities (contact tracing: [@CD011432-bbs2-0001]; [@CD011432-bbs2-0007]; [@CD011432-bbs2-0013]; outreach clinics: [@CD011432-bbs2-0003]; [@CD011432-bbs2-0007]; [@CD011432-bbs2-0015]; house‐to‐house screening: [@CD011432-bbs2-0002]; [@CD011432-bbs2-0003]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0007]; [@CD011432-bbs2-0010]; [@CD011432-bbs2-0011]; [@CD011432-bbs2-0014]; [@CD011432-bbs2-0017]), 13 studies included some form of health promotion activities to encourage people to attend health facilities for tuberculosis screening and testing ([@CD011432-bbs2-0001]; [@CD011432-bbs2-0003]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0006]; [@CD011432-bbs2-0007]; [@CD011432-bbs2-0008]; [@CD011432-bbs2-0010]; [@CD011432-bbs2-0013]; [@CD011432-bbs2-0014]; [@CD011432-bbs2-0015]; [@CD011432-bbs2-0016]; [@CD011432-bbs2-0017]), and most studies included training activities to improve the diagnostic skills available at health facilities (see [Table 13](#CD011432-tbl-0013){ref-type="table"}).Table 1Descriptions of study interventions: Interventions to increase tuberculosis case detection compared to no intervention**Study IDStudy design1. Did health workers look for tuberculosis cases outside of health facilities?2. Were there health promotion activities to encourage people with symptoms to attend health services?3. Were health workers trained in tuberculosis diagnosis?Yes/NoWhere?Yes/NoHow were health promotion messages delivered?Yes/NoWho was trained?What training did they receive?**[@CD011432-bbs2-0001]Cluster‐RCTYesHouseholds of people with new tuberculosis diagnosisYesCommunity/school‐based drama, meetings, leafleting, football matches, fashion showsUnclear------[@CD011432-bbs2-0015]Cluster‐RCTYesMonthly community outreach clinicsYesCommunity promoters visited houses and distributed leaflets.YesNurses and health officers4‐day training on case identification, diagnostic process, and outreach co‐ordination[@CD011432-bbs2-0004]Cluster‐RCTYesHouse‐to‐house visits every 2 to 4 weeks^1^YesHealth education sessions at health postsYesHealth extension workers2‐day training on symptoms, collection, storage, and transport of sputum samples[@CD011432-bbs2-0002]Cluster‐RCTYesMonthly screening of all farm workersNo---YesLay health workers---[@CD011432-bbs2-0017]CBASYesHouse‐to‐house visits every 2 to 4 weeksYesCommunity meetings, campaigns, and local radio\
Awareness workshops for religious leaders, teachers, and other stakeholdersYesHealth extension workers and laboratory staffUnclear how long the training was or what it covered[@CD011432-bbs2-0007]CBASYesHousehold contact tracing, mobile chest camps in hard‐to‐reach areas, home visits for children with HIV, and school‐based screeningYesThrough safe motherhood clinicsUnclear------[@CD011432-bbs2-0013]CBASYesScreening of home contacts, at outpatient clinics, and at ART clinicsYesHandbills and posters distributed in hospitals, schools, and homes, plus visits to primary schools.YesMedical officers and nursesTuberculosis diagnosis and using job aids[@CD011432-bbs2-0014]CBASYesCommunity volunteers visited homes.YesInformation, education, and communication materials given to each visited house.UnclearVolunteers described as \"trained\"---[@CD011432-bbs2-0011]Cluster‐RCTYesHealthcare workers and community volunteers visited homes.No‐YesHealthcare workers and selected volunteersHow to screen target population[@CD011432-bbs2-0001]Cluster‐RCTNo---YesCommunity/school‐based drama, meetings, leafleting, football matches, fashion showsUnclear------[@CD011432-bbs2-0016]Cluster‐RCTNo---YesHealth education sessions at health centres and community meetingsYesTuberculosis control assistants and doctorsThe 2‐day training course included the use of the Keith Edwards Child Tuberculosis score chart, administration of the Mantoux test, weighing children and interpreting level of malnutrition, referral of children to the doctor when needed and filling out a research questionnaire.[@CD011432-bbs2-0008]CBASNo---YesBillboards, TV ads, posters, flyersYesLay peopleTraining session on NTP guidelines[@CD011432-bbs2-0006]CBASNo---YesNewspaper advertisements and inserts, television and radio announcements, and chat showsNo------[@CD011432-bbs2-0005]Cluster‐RCTNo---No---YesNurses3 to 4 education sessions lasting 1 to 3 hours[@CD011432-bbs2-0009]NRTNo---------YesDistrict tuberculosis co‐ordinators and medical officersMonitoring guidelines and tools[^7]

Sixteen studies evaluated case‐finding interventions compared to standard passive case finding at health facilities, while three studies provided direct head‐to‐head comparisons of different case‐finding interventions ([@CD011432-bbs2-0001]; [@CD011432-bbs2-0003]; [@CD011432-bbs2-0010]).

Most studies presented the raw data for the number of tuberculosis cases detected (microbiologically confirmed) in a defined population, but only three presented an estimate of effect appropriately adjusted for the cluster design. Only one study attempted to evaluate the effects of interventions on long‐term tuberculosis prevalence ([@CD011432-bbs2-0001]), and this study measured prevalence at 3.5 to 4.5 years after the intervention had begun.

Thirteen studies used a symptom questionnaire as an entry point for microbiological testing. Sputum microscopy was used to diagnose tuberculosis in 17 studies. In addition, three studies conducted mycobacterial culture and chest X‐ray ([@CD011432-bbs2-0001]; [@CD011432-bbs2-0003]; [@CD011432-bbs2-0005]); one study added chest X‐ray to symptoms screening to screen presumptive tuberculosis patients ([@CD011432-bbs2-0011]); two studies used a tuberculin skin test ([@CD011432-bbs2-0007]; [@CD011432-bbs2-0012]); and two studies used GeneXpert MTB/RIF ([@CD011432-bbs2-0008]; [@CD011432-bbs2-0011]).

### Excluded studies {#CD011432-sec3-0020}

We excluded 56 studies because they did not meet the inclusion criteria. The reasons for their exclusion are presented in the [Characteristics of excluded studies](#CD011432-sec2-0020){ref-type="sec"} section.

Eight references remain unclassified as we have been unable to access full‐text copies: three conference abstracts ([@CD011432-bbs2-0076]; [@CD011432-bbs2-0078]; [@CD011432-bbs2-0080]), two Chinese language studies ([@CD011432-bbs2-0074]; [@CD011432-bbs2-0075]), two old publications ([@CD011432-bbs2-0077]; [@CD011432-bbs2-0081]), and one reference that we have been unable to trace ([@CD011432-bbs2-0079]).

Risk of bias in included studies {#CD011432-sec2-0009}
--------------------------------

For a summary of the \'Risk of bias\' assessments see [Figure 3](#CD011432-fig-0003){ref-type="fig"}.Figure 3\'Risk of bias\' summary: review authors\' judgements about each \'Risk of bias\' item for each included trial.

### Allocation {#CD011432-sec3-0021}

Five out of nine cluster‐randomized studies adequately described a suitable method for generating the random sequence and were judged to be at low risk of selection bias ([@CD011432-bbs2-0001]; [@CD011432-bbs2-0002]; [@CD011432-bbs2-0003]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0005]); in the other four the description was unclear. Although allocation concealment was not described for most of the cluster‐randomized studies, cluster‐randomized studies are normally considered to be at low risk of selection bias as the allocation of all clusters is usually done in a single step.

We judged the non‐randomized trials to be at high risk of selection bias.

### Blinding {#CD011432-sec3-0022}

None of the trials described blinding of health workers or populations (and this would have been impossible to do), but this is unlikely to bias the measured effects of the intervention.

Five of the randomized studies blinded microscopists or outcome assessors to the treatment allocation and were judged to be at low risk of detection bias ([@CD011432-bbs2-0001]; [@CD011432-bbs2-0003]; [@CD011432-bbs2-0005]; [@CD011432-bbs2-0012]).

### Incomplete outcome data {#CD011432-sec3-0023}

Seven studies were at low risk of attrition bias ([@CD011432-bbs2-0001]; [@CD011432-bbs2-0002]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0005]; [@CD011432-bbs2-0011]; [@CD011432-bbs2-0015]; [@CD011432-bbs2-0016]), and the other 10 studies were at unclear risk of attrition bias ([@CD011432-bbs2-0003]; [@CD011432-bbs2-0006]; [@CD011432-bbs2-0007]; [@CD011432-bbs2-0008]; [@CD011432-bbs2-0010]; [@CD011432-bbs2-0012]; [@CD011432-bbs2-0013]; [@CD011432-bbs2-0014]; [@CD011432-bbs2-0017])

### Selective reporting {#CD011432-sec3-0024}

We identified one study with unclear risk of selective reporting bias ([@CD011432-bbs2-0013]).

### Other potential sources of bias {#CD011432-sec3-0025}

We identified no other sources of bias.

Effects of interventions {#CD011432-sec2-0010}
------------------------

See: [Table 1](#CD011432-tbl-0001){ref-type="table"}; [Table 2](#CD011432-tbl-0002){ref-type="table"}; [Table 3](#CD011432-tbl-0003){ref-type="table"}; [Table 4](#CD011432-tbl-0004){ref-type="table"}; [Table 5](#CD011432-tbl-0005){ref-type="table"}

### Comparison 1: Outreach tuberculosis screening with or without health promotion activities versus no intervention {#CD011432-sec3-0026}

See [Table 1](#CD011432-tbl-0001){ref-type="table"}.

Four cluster‐RCTs and four controlled before‐and‐after studies evaluated the effects of tuberculosis diagnostic outreach services into the community. All but one of these interventions also included extensive health promotion activities. For details see [Table 13](#CD011432-tbl-0013){ref-type="table"} and [Table 14](#CD011432-tbl-0014){ref-type="table"}.Table 2Descriptions of study settings, tuberculosis screening protocols, and tuberculosis notification rates**Study IDStudy designCountrySettingScreening testConfirmatory testTuberculosis CNR per 100,000 person years^1^ (unadjusted for cluster design)Baseline tuberculosis CNR comparable between study arms?InterventionControl**[@CD011432-bbs2-0001]Cluster‐RCTZambia and South AfricaUrban and ruralSymptomatic and non‐symptomatic individualsSputum smear microscopy and culture------Not reported[@CD011432-bbs2-0015]Cluster‐RCTEthiopiaRuralSymptom screen: criteria not definedSputum smear microscopy12598Not reported[@CD011432-bbs2-0004]Cluster‐RCTEthiopiaRuralSymptom screen: cough for \> 2 weeksSputum smear microscopy12974Not reported[@CD011432-bbs2-0002]Cluster‐RCTSouth AfricaRuralSymptom screen: criteria not definedSputum smear microscopy and culture14871843Yes[@CD011432-bbs2-0017]Non‐randomizedEthiopiaUrban and ruralSymptom screen: cough \> 2 weeksSputum smear microscopy127---Not reported[@CD011432-bbs2-0007]Non‐randomizedNepalUrban and ruralSymptom screenSputum smear microscopy or CXR, tuberculin test, and physician assessment24.215.6No[@CD011432-bbs2-0013]Non‐randomizedNigeriaUrban and ruralSymptom screenSputum smear microscopy or Keith Edwards Tuberculosis score chart------Not reported[@CD011432-bbs2-0014]Non‐randomizedIndiaUrban and ruralUnclearSputum smear microscopy------Not reported[@CD011432-bbs2-0016]Cluster‐RCTBangladeshUrban and ruralNone described.Keith Edwards Child Tuberculosis Score Chart------Not reported[@CD011432-bbs2-0008]Non‐randomizedPakistanUrbanSymptom screen: cough \> 3 weeks or productive cough \> 2 weeksSputum smear microscopy, GeneXpert, or CXR34341No[@CD011432-bbs2-0006]Non‐randomizedColombiaUrbanNone described.Sputum smear microscopy------Not reported[@CD011432-bbs2-0005]Cluster‐RCTSouth AfricaUrban and ruralSymptom screen: criteria not definedSputum smear microscopy and culture/CXR, clinical diagnosis (evidence‐treatment card)------Not reported[@CD011432-bbs2-0003]Cluster‐RCTZimbabweUrbanSymptom screen: cough for \> 2 weeksSputum smear microscopy and culture427380Yes[@CD011432-bbs2-0010]Cluster‐RCTBrazilUrbanSymptom screen: cough for \> 3 weeksSputum smear x 2 plus CXR934604Yes[@CD011432-bbs2-0011]Cluster‐RCTCambodiaUrban and ruralSymptoms screening: cough, fever, weight loss, and/or night sweats of more than 2 weeks and household contacts without symptomsGene Xpert MTB/RIF323254Yes[@CD011432-bbs2-0012]Individual‐RCTSouth AfricaUrbanTuberculosis symptom screening and tuberculosis contactSputum smear microscopy and culture---------[^8]

Of the cluster‐RCTs, [@CD011432-bbs2-0001] screened all household contacts of people with active tuberculosis; [@CD011432-bbs2-0015] conducted monthly diagnostic outreach clinics in each cluster; [@CD011432-bbs2-0004] used health extension workers who visited every household every two weeks to screen for tuberculosis; and [@CD011432-bbs2-0011] used healthcare workers and community volunteers who screened households for a period of one year. [@CD011432-bbs2-0002] was a much smaller trial in which lay health workers screened all farm workers for tuberculosis every month.

Of the non‐randomized studies, [@CD011432-bbs2-0017] and [@CD011432-bbs2-0014] screened for active tuberculosis in people\'s homes; [@CD011432-bbs2-0007] used volunteers to conduct contact tracing, set up mobile clinics, and screen at homes and schools; and [@CD011432-bbs2-0013] conducted contact tracing plus screening at outpatient clinics and antiretroviral therapy clinics.

#### Tuberculosis cases detected (microbiologically confirmed) {#CD011432-sec4-0007}

Among the cluster‐RCTs, only [@CD011432-bbs2-0015] and [@CD011432-bbs2-0004] presented estimates of the effect of the intervention on tuberculosis case detection (microbiologically confirmed) that were appropriately adjusted for the cluster design (see [Table 15](#CD011432-tbl-0015){ref-type="table"}). However, as both studies used different measures of effect, we have presented an alternative analysis approximately adjusted for the cluster design using the most conservative ICC (from [@CD011432-bbs2-0004]).Table 3Primary tuberculosis case‐finding outcome for studies of tuberculosis outreach diagnostic services**Study IDStudy designOutcome measureInterventionControlEffect estimate**\
**(95% CI)Adjusted for cluster designComment**[@CD011432-bbs2-0001]Cluster‐RCT------------NATuberculosis case detection is not reported. The primary outcome is long‐term tuberculosis prevalence.[@CD011432-bbs2-0015]Cluster‐RCTTuberculosis case notification rate per 100,000 person years during the intervention12598**Difference 27**\
(‐19 to 72)YesP = 0.12\
ICC = 0.00027[@CD011432-bbs2-0004]Cluster‐RCTTuberculosis case detection rate as a percentage of the average annual case detection rate122.2%69.4%**Difference 52.4%**\
(39.8 to 65.4)YesP \< 0.001\
ICC = 0.00052[@CD011432-bbs2-0002]Cluster‐RCTThe number of clusters with higher case finding during the intervention period26/10618/105**Difference 8.9%**\
(‐0.7 to 24.9)NAP = 0.29[@CD011432-bbs2-0017]Non‐randomizedTuberculosis case notification rate per 100,000 person years127------NAOnly the intervention area data are presented as a before‐and‐after analysis. No statistical significance testing was done.[@CD011432-bbs2-0007]Non‐randomizedChange in childhood tuberculosis case notification per 100,000 compared to previous year+6%+2.2%**Difference**\
**3.8%**\
(2.7 to 5.2)NAP \< 0.001[@CD011432-bbs2-0013]Non‐randomizedChange in tuberculosis cases identified+31%Not statedNot statedNAOnly data from the intervention areas are presented.[@CD011432-bbs2-0014]Non‐randomizedChange in number of smear‐positive tuberculosis cases compared to previous year+8.8%‐8.6%---NAOnly the number of cases detected is presented, without denominators.[^9]

[Analysis 1.1](#CD011432-fig-00101){ref-type="fig"} presents the findings of four studies ([@CD011432-bbs2-0002]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0011]; [@CD011432-bbs2-0015]), the number of tuberculosis cases detected (microbiologically confirmed) may increase in the intervention groups (risk ratio (RR) 1.24, 95% CI 0.86 to 1.79; 4 trials, 163,043 participants in 297 clusters, *low‐certainty evidence*). We further analysed by tuberculosis prevalence and presented in [Analysis 1.2](#CD011432-fig-00102){ref-type="fig"}. [Analysis 1.2](#CD011432-fig-00102){ref-type="fig"} presents the findings of four studies ([@CD011432-bbs2-0002]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0011]; [@CD011432-bbs2-0015]), which we subgrouped by tuberculosis prevalence of less than 5% ([@CD011432-bbs2-0002]) and 5% or more ([@CD011432-bbs2-0004]; [@CD011432-bbs2-0011]; [@CD011432-bbs2-0015]). The study among farm workers in South Africa found with calculate prevalence of less than 5% showed no obvious effect of the intervention (RR 0.85, 95% CI 0.60 to 1.19; 1 trial, 8887 participants, [Analysis 1.2](#CD011432-fig-00102){ref-type="fig"}). In the studies by [@CD011432-bbs2-0004], [@CD011432-bbs2-0011], and [@CD011432-bbs2-0015], the number of tuberculosis cases detected was higher in the intervention areas (RR 1.52, 95% CI 1.10 to 2.09; 3 trials, 155,918 participants in 51 clusters, [Analysis 1.2](#CD011432-fig-00102){ref-type="fig"}, *low‐certainty evidence*).

[Analysis 1.3](#CD011432-fig-00103){ref-type="fig"} presents the tuberculosis cases detected microbiologically confirmed by intervention. Overall, the point estimates were similar the overall combined interventions as presented in [Analysis 1.1](#CD011432-fig-00101){ref-type="fig"}. Tuberculosis outreach clinics plus health promotion ([@CD011432-bbs2-0015]) may increase tuberculosis cases detected (RR 1.28, 95% CI 0.76 to 2.17, Analysis 1.3.1). Similarly, the house‐to‐house screening plus health promotion for three cluster‐RCTs ([@CD011432-bbs2-0002]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0011]) may increase tuberculosis cases detected (RR 1.25, 95% CI 0.75 to 2.08, Analysis 1.3.2).

The cluster‐RCT by [@CD011432-bbs2-0011] reported \"TB cases detected (all forms)\", and the results were consistent with the effects seen in studies that reported microbiologically confirmed tuberculosis cases detected with RR 1.28 (95% CI 0.83 to 1.98, [Analysis 1.4](#CD011432-fig-00104){ref-type="fig"}).

Of the non‐randomized studies, [@CD011432-bbs2-0017] and [@CD011432-bbs2-0007] reported increases in tuberculosis case notification per 100,000 in the intervention areas compared to control areas (see [Table 15](#CD011432-tbl-0015){ref-type="table"}); [@CD011432-bbs2-0013] and [@CD011432-bbs2-0014] only reported the number of tuberculosis cases detected without clear denominators, but both reported increased numbers in the intervention areas compared to the pre‐intervention period (+31% and +8%, respectively).

#### Tuberculosis treatment outcomes {#CD011432-sec4-0008}

None of the studies included in this review adjusted for clustering for the treatment outcomes that they reported. We therefore used a conservative ICC of 0.001 for all the treatment outcomes.

Treatment default was substantially lower in those diagnosed through outreach services compared to standard health facilities (mean treatment default across studies: 10% versus 16%; RR 0.67, 95% CI 0.47 to 0.96; [Analysis 1.5](#CD011432-fig-00105){ref-type="fig"}, *low‐certainty evidence*). In all three randomized trials reporting tuberculosis treatment outcomes, treatment success was slightly higher in the intervention groups compared to the control group (mean treatment success across studies: 84% versus 78%). Although the direction of the effect was towards the intervention, there was very little difference indicated by the point estimate (RR 1.07, 95% CI 1.00 to 1.15; [Analysis 1.6](#CD011432-fig-00106){ref-type="fig"}, *low‐certainty evidence*). The number of treatment failures and deaths was low in all three randomized trials, so the analysis of differences was underpowered (treatment failures: RR 1.57, 95% CI 0.50 to 4.92; [Analysis 1.7](#CD011432-fig-00107){ref-type="fig"}; tuberculosis mortality: RR 0.99, 95% CI 0.43 to 2.25, [Analysis 1.8](#CD011432-fig-00108){ref-type="fig"}, 849 patients, very *low‐certainty evidence*). Only one of the non‐randomized studies reported treatment outcomes ([@CD011432-bbs2-0017]).

People diagnosed in intervention areas had higher treatment success (85% versus 77%), and lower default (3% versus 11%) during the implementation period compared to the pre‐intervention period ([@CD011432-bbs2-0017]).

#### Long‐term tuberculosis prevalence {#CD011432-sec4-0009}

Only [@CD011432-bbs2-0001] evaluated the effects on long‐term prevalence of tuberculosis. In a cross‐sectional prevalence study, 3.5 to 4.5 years after the intervention started, there was no effect demonstrated (881 per 100,000 intervention areas versus 773 per 100,000 control areas; RR 1.14, 95% CI 0.65 to 2.00; 1 study, 556,836 participants in 12 clusters, [Analysis 1.9](#CD011432-fig-00109){ref-type="fig"}, *very low‐certainty evidence*). The authors also presented an additional analysis adjusted for multiple confounders such as tuberculosis and HIV prevalence, household socioeconomic status, age, sex, and smoking history, with no obvious effect detected (RR 0.89, 95% CI 0.62 to 1.29).

### Comparison 2: Health promotion activities versus no intervention {#CD011432-sec3-0027}

See [Table 2](#CD011432-tbl-0002){ref-type="table"}.

Two cluster‐RCTs, [@CD011432-bbs2-0001] and [@CD011432-bbs2-0016], and two non‐randomized studies, [@CD011432-bbs2-0008] and [@CD011432-bbs2-0006], evaluated health promotion activities that encourage attendance at health services for tuberculosis screening.

These health promotion activities ranged from extensive mass media strategies (television/radio/newspapers) to more local, community‐based activities (leafleting, community meetings, school‐based drama). For details see [Table 13](#CD011432-tbl-0013){ref-type="table"}.

#### Tuberculosis cases detected (microbiologically confirmed) {#CD011432-sec4-0010}

Neither of the two cluster‐RCTs presented an estimate of the effect of the intervention on tuberculosis case detection (see [Table 16](#CD011432-tbl-0016){ref-type="table"}). [@CD011432-bbs2-0001] used long‐term tuberculosis prevalence as the primary outcome, and [@CD011432-bbs2-0016] only reported the number of people referred for testing in intervention areas without a population‐level denominator. However, [@CD011432-bbs2-0016] reported that the number of cases detected was higher in the intervention areas (P = 0.001; author\'s own figures).Table 4Primary tuberculosis case‐finding outcome for studies of health promotion**Study IDStudy designOutcome measureInterventionControlEffect estimate**\
**(95% CI)Adjusted for cluster designComment**[@CD011432-bbs2-0001]Cluster‐RCT------------NATuberculosis case detection was not reported. The primary outcome was long‐term tuberculosis prevalence.[@CD011432-bbs2-0016]Cluster‐RCTNumber of tuberculosis cases diagnosed175130No significance testing was done between intervention and control areas.NAThe number of tuberculosis cases diagnosed in the intervention area was higher during the intervention compared to pre‐intervention (P = 0.001).[@CD011432-bbs2-0008]Non‐randomizedTuberculosis case detection per 100,00034341No significance testing was done between intervention and control areas.NAThe tuberculosis case notification in the intervention area increased 2‐fold during the intervention (P = 0.000).[@CD011432-bbs2-0006]Non‐randomizedNumber of tuberculosis cases/number of people tested------No significance testing was done between intervention and control areas.NAA temporal association is noted between the number of people being tested and the intervention. There is not a convincing corresponding increase in the number of new tuberculosis diagnoses.[^10]

Of the two non‐randomized studies, [@CD011432-bbs2-0008] reported that tuberculosis case detection doubled during the intervention period (343 per 100,000 during intervention versus 176 per 100,000 pre‐intervention), but remained stable in the parallel control area (46 per 100,000 during intervention versus 41 per 100,000 pre‐intervention). [@CD011432-bbs2-0006] only presented quarterly data on the number of smears conducted, the number of people tested, and the number of tuberculosis cases notified. These data suggest a temporal association between the intervention period and an increase in the number of smears and people tested. However, there was not a convincing corresponding increase in the number of tuberculosis case notifications.

#### Long‐term tuberculosis prevalence {#CD011432-sec4-0011}

[@CD011432-bbs2-0001] conducted a cross‐sectional prevalence study 3.5 to 4.5 years after the intervention started. There was no effect demonstrated on tuberculosis prevalence at this time point (1012 per 100,000 intervention areas versus 773 per 100,000 control areas; RR 1.31, 95% CI 0.75 to 2.29; 1 trial, 405,788 participants in 12 clusters, [Analysis 2.1](#CD011432-fig-00201){ref-type="fig"}, *very low‐certainty evidence*). The authors presented an additional analysis adjusted for multiple confounders such as tuberculosis and HIV prevalence, household socioeconomic status, age, sex, and smoking history, but did not demonstrate a difference (RR 1.04, 95% CI 0.72 to 1.51).

#### Tuberculosis treatment outcomes {#CD011432-sec4-0012}

None of the studies reported comparisons of tuberculosis treatment outcomes between intervention and control areas, or between pre‐ and post‐intervention periods.

### Comparison 3: Staff training compared to none {#CD011432-sec3-0028}

See [Table 3](#CD011432-tbl-0003){ref-type="table"}

One cluster‐RCT evaluated health worker education compared to no intervention ([@CD011432-bbs2-0005]). In South Africa, nurse practitioners working in primary care clinics were given between two and six educational sessions. One quasi‐experimental study evaluated nurses who were trained on case management and monitoring tools in participating health facilities ([@CD011432-bbs2-0009]). A summary of the tuberculosis case‐finding outcomes for the two studies is shown in [Table 17](#CD011432-tbl-0017){ref-type="table"}.Table 5Tuberculosis case‐finding outcome for studies of health staff training in tuberculosis diagnosis**Study IDStudy designOutcome measureInterventionControlEffect estimate**\
**(95% CI)Adjusted for cluster designComment**[@CD011432-bbs2-0005]Cluster‐RCTNew tuberculosis cases detected per 1000 patients5734**Odds ratio 1.72**\
(1.04 to 2.85)YesP = 0.04\
ICC = 0.007[@CD011432-bbs2-0009]Non‐randomizedThe proportion of new tuberculosis cases that were diagnosed in primary care20/76706/7536**Odds ratio 3.28**\
(1.26 to 9.97)YesP = 0.007\
ICC = 0.00052[^11]

#### Tuberculosis cases detected (microbiologically confirmed) {#CD011432-sec4-0013}

In South Africa, [@CD011432-bbs2-0005] reported an increase in the number of tuberculosis cases diagnosed per 1000 patient consults (RR 1.68, 95% CI 1.03 to 2.72; 1 trial, 1999 participants, [Analysis 3.1](#CD011432-fig-00301){ref-type="fig"}, *low‐certainty evidence*). One non‐randomized study, [@CD011432-bbs2-0009], reported that tuberculosis case detection more than tripled in the intervention group (511 tuberculosis cases per 100,000 in the intervention group versus 135 tuberculosis cases per 100,000 in the control group).

Other outcomes, including tuberculosis treatment outcomes and long‐term tuberculosis prevalence, were not reported.

### Comparison 4: Outreach tuberculosis screening versus health promotion {#CD011432-sec3-0029}

See [Table 4](#CD011432-tbl-0004){ref-type="table"}

Two cluster‐RCTs directly compared outreach tuberculosis screening with health promotion activities. [@CD011432-bbs2-0001] compared tuberculosis contact tracing with extensive health promotion activities encouraging health service attendance, and [@CD011432-bbs2-0010] compared house‐to‐house screening with the distribution of informational leaflets to all households (see [Table 18](#CD011432-tbl-0018){ref-type="table"}).Table 6Descriptions of study interventions: Direct comparisons of different interventions to increase tuberculosis case detection**Study IDStudy designStudy arm1. Did health workers look for tuberculosis cases outside of health facilities?2. Were there health promotion activities to encourage people with symptoms to attend health services?3. Were health workers trained in tuberculosis diagnosis?Yes/NoWhere?Yes/NoHow were health promotion messages delivered?Yes/NoWho was trained?What training did they receive?**[@CD011432-bbs2-0001]Cluster‐RCT1YesHouseholds of people with new tuberculosis diagnosisYesCommunity/school‐based drama, meetings, leafleting, football matches, fashion showsUnclear------2No---YesCommunity/school‐based drama, meetings, leafleting, football matches, fashion showsUnclear------3YesHouseholds of people with new tuberculosis diagnosisNo---Unclear------[@CD011432-bbs2-0010]Cluster‐RCT1YesAll households visited.No---Not described------2No---YesAll households received an informational pamphlet linked with a national TV campaign encouraging those with symptoms to seek free care.Not described------[@CD011432-bbs2-0003]Cluster‐RCT1YesMobile van situated in each cluster for 5 days every 6 months.YesA loud speaker and leafleting encouraging people to attendNot described------2YesHouse‐to‐house visits every 6 months, with up to 3 visits each round (including 1 weekend day) to ensure coverageYesLeaflets explained the rationale and benefits.Not described------[^12]

#### Tuberculosis cases detected (microbiologically confirmed) {#CD011432-sec4-0014}

Only [@CD011432-bbs2-0010] reported the effect on tuberculosis case detection. During the study period, tuberculosis case detection was higher with house‐to‐house screening than with health promotion (9.34 per 1000 person years versus 6.04 per 1000 person years; rate ratio 1.55, 95% CI 1.10 to 1.99, 1 trial, 23,553 participants in 14 clusters, [Analysis 4.1](#CD011432-fig-00401){ref-type="fig"}). However, a second analysis including the intervention period plus 60 days postintervention attenuated this apparent effect (RR 1.05, 95% CI 0.56 to 1.54). See [Table 19](#CD011432-tbl-0019){ref-type="table"}.Table 7Primary tuberculosis case‐finding outcome for studies comparing different interventions**Study IDStudy designOutcome measureInterventionControlEffect estimate**\
**(95% CI)Adjusted for cluster designCommentOutreach tuberculosis services versus health promotion**[@CD011432-bbs2-0001]Cluster‐RCT------------NATuberculosis case detection was not reported. The primary outcome was long‐term tuberculosis prevalence.[@CD011432-bbs2-0010]Cluster‐RCTTuberculosis case notification rate per 1000 person years during the intervention period9.346.04**Rate ratio 1.55**\
(1.10 to 1.99)YesThe authors report a second analysis including cases detected during the first 60 days postintervention. The result was no longer statistically significant.**Outreach tuberculosis clinic versus household screening**[@CD011432-bbs2-0003]Cluster‐RCTMean cumulative yield of tuberculosis smear‐positive cases per 1000 adults per cluster over 3 years\' follow‐up4.222.46**Risk ratio 1.71**\
(1.27 to 2.31)YesA second analysis also adjusted for cluster‐level variation in household crowding, age, sex, HIV infection, and pre‐study tuberculosis notification rates was also statistically significant.[^13]

#### Long‐term prevalence {#CD011432-sec4-0015}

The cluster‐RCT from Zambia and South Africa was a cross‐sectional prevalence study 3.5 to 4.5 years after the intervention started ([@CD011432-bbs2-0001]). The study had four arms: control arm, health promotion activities, contact tracing, and contact tracing plus health promotion. None of the interventions were shown to reduce prevalence compared to control.

#### Tuberculosis treatment outcomes {#CD011432-sec4-0016}

[@CD011432-bbs2-0010] reported that time to diagnosis and treatment completion were not significantly different between the two groups.

### Comparison 5: Outreach clinic versus house‐to‐house screening {#CD011432-sec3-0030}

See [Table 5](#CD011432-tbl-0005){ref-type="table"}

One cluster‐RCT directly compared the effects of a six‐monthly outreach tuberculosis clinic (a mobile van) versus six‐monthly house‐to‐house screening (see [Table 18](#CD011432-tbl-0018){ref-type="table"}) ([@CD011432-bbs2-0003]).

#### Tuberculosis cases detected (microbiologically confirmed) {#CD011432-sec4-0017}

The number of tuberculosis cases detected was higher with the outreach clinic in each of the six rounds of the interventions, and the cumulative case detection over the three years of the trial was 48% higher (RR 1.48, 95% CI 1.11 to 1.97; 1 trial, 405,819 participants, [Analysis 5.1](#CD011432-fig-00501){ref-type="fig"}, *very low‐certainty evidence*). The authors note that this was unexpected, as the mobile clinic is a less intensive method of case finding, and required self presentation at a public clinic specializing in the diagnosis of a disease associated with poverty and HIV. The authors acknowledge this and suggest that the mobile clinic may have been more convenient, and allowed people to encourage those with symptoms to attend. The home visits were conducted between 9 am and 4 pm, when many people may have been absent, but repeated visits (up to three) including at least one weekend visit attempted to mitigate this.

#### Long‐term tuberculosis prevalence {#CD011432-sec4-0018}

[@CD011432-bbs2-0003] reported that overall tuberculosis prevalence declined by around 44% over the three years of the intervention (95% CI 17% to 62%; author\'s own figures), with no difference detected between the two interventions; however, this is an uncontrolled observation that could be part of a wider temporal trend unassociated with the intervention.

#### Tuberculosis treatment outcomes {#CD011432-sec4-0019}

Not described.

### Comparison 6: Active case‐finding interventions versus no intervention {#CD011432-sec3-0031}

In this comparison we evaluated any interventions that had any component of active case finding versus no intervention. We included five studies ([@CD011432-bbs2-0002]; [@CD011432-bbs2-0004]; [@CD011432-bbs2-0005]; [@CD011432-bbs2-0011]; [@CD011432-bbs2-0015]). The results did not differ from comparison one to four ([Analysis 6.1](#CD011432-fig-00601){ref-type="fig"}; [Analysis 6.2](#CD011432-fig-00602){ref-type="fig"}; [Analysis 6.3](#CD011432-fig-00603){ref-type="fig"}; [Analysis 6.4](#CD011432-fig-00604){ref-type="fig"}; [Analysis 6.5](#CD011432-fig-00605){ref-type="fig"}; [Analysis 6.6](#CD011432-fig-00606){ref-type="fig"}; [Analysis 6.7](#CD011432-fig-00607){ref-type="fig"}; [Analysis 6.8](#CD011432-fig-00608){ref-type="fig"}; [Analysis 6.9](#CD011432-fig-00609){ref-type="fig"}).

### Comparison 7: Outreach tuberculosis services versus no intervention (sensitivity analyses) {#CD011432-sec3-0032}

In this comparison we included studies that did not present ICC for the tuberculosis treatment outcome (tuberculosis treatment default, tuberculosis treatment success, tuberculosis treatment failure, and tuberculosis mortality). This comparison demonstrates the results for conservative ICC of 0.001 and the ICC as given by [@CD011432-bbs2-0004]. The results did not differ when adjusting for each of the ICCs considered ([Analysis 7.5](#CD011432-fig-00705){ref-type="fig"}; [Analysis 7.6](#CD011432-fig-00706){ref-type="fig"}; [Analysis 7.7](#CD011432-fig-00707){ref-type="fig"}; [Analysis 7.8](#CD011432-fig-00708){ref-type="fig"}).

Discussion {#CD011432-sec1-0006}
==========

Summary of main results {#CD011432-sec2-0011}
-----------------------

Tuberculosis outreach screening (with and without health promotion) to encourage presumptive tuberculosis patients to attend healthcare services may increase tuberculosis case detection in settings where the prevalence of undiagnosed tuberculosis disease is high. This was shown in four cluster‐RCTs (*low‐certainty evidence*).

Regular tuberculosis diagnostic outreach clinics may also increase tuberculosis case detection (*low‐certainty evidence*).

There is insufficient evidence to determine if sustained improvements in case detection impact on long‐term tuberculosis prevalence, as the only controlled study to evaluate this found no effect after four years of contact tracing plus intensive health promotion intervention (*very low‐certainty evidence*).

In all of these trials, there were modest effects on treatment success and default from treatment in participants diagnosed through outreach/screening services (*moderate‐certainty evidence*).

Overall completeness and applicability of evidence {#CD011432-sec2-0012}
--------------------------------------------------

We included 17 studies in this review, which have implemented various interventions with contradictory results. Some of the interventions may have a large effect on increasing tuberculosis case detection (microbiologically confirmed), whereas other interventions showed no evidence of being effective. This is perhaps not unexpected, as the efficacy of any tuberculosis case‐finding intervention is likely to be dependent on multiple factors such as the prevalence of undiagnosed tuberculosis, local barriers to accessing care, and the practical details of implementation, which may include tuberculosis diagnostic tool used. While we will discuss some of the potential reasons for the presence or absence of demonstrable effects, the limited number of studies for each intervention, and the very limited number of settings in which these interventions have been implemented, limit our ability to make broad generalizations.

The study by [@CD011432-bbs2-0003] from Zimbabwe is particularly interesting as it brings up as many questions as it answers. For those considering periodic tuberculosis diagnostic outreach clinics as the most feasible and affordable option in their setting, this study provides some reassurance that these clinics can be effective. Indeed, the lack of demonstrable effect of monthly clinics in [@CD011432-bbs2-0015] may simply be due to the statistical imprecision of the trial (that is, the intervention was effective but a bigger trial was needed to demonstrate this), or may reflect suboptimal implementation of the clinics (that is, they were conducted in the wrong place at the wrong time or were inadequately publicized).

However, the finding that six‐monthly outreach clinics were actually more effective than house‐to‐house visits needs to be interpreted with caution, as it is counterintuitive. The explanation offered by the study authors was that the monthly clinics were somehow more acceptable or accessible to the population. This explanation is reasonable, but again demonstrates how reliant the effects of any intervention are on the practical details of implementation, such as the timing of visits. The intervention effect might disappear or even reverse with different cultural norms, different attitudes towards tuberculosis, or different timing or settings for the clinics or home visits.

[@CD011432-bbs2-0003] also presented evidence of a declining prevalence in tuberculosis over the three years of the study, which was notably absent in the trial by [@CD011432-bbs2-0001]. The interventions in the two trials are obviously different, and one interpretation for the results might be that contact tracing and health promotion alone are not sufficient to reduce tuberculosis prevalence, whereas outreach clinics and household screening are. However, the evidence from [@CD011432-bbs2-0003] is observational in nature, and highly susceptible to confounding. It is also surprising that the same decline was seen in both study arms despite a clear difference in tuberculosis case detection between the two arms. The decline may therefore be due to other temporal trends or activities, rather than the case‐finding intervention itself.

The overall limitations of the studies included in this review are as follows.

Small sample sizes that were not powered to detect a clinical difference in tuberculosis treatment outcomes such as mortality and default rate.The likelihood of false‐positive results from sputum smear acid‐fast bacilli (AFB) microscopy, especially in low tuberculosis prevalence settings, with implications for the overestimation of notification rates and favourable treatment outcomes (treatment success).Considerable heterogeneity of interventions that reduced the certainty of the evidence of each reviewed outcome.Considerable heterogeneity of the health systems in which the interventions were implemented.

Quality of the evidence {#CD011432-sec2-0013}
-----------------------

We assessed the certainty of the evidence in this review using the GRADE approach and presented the evidence in five \'Summary of findings\' tables.

We generally downgraded the certainty of evidence for the primary outcome of tuberculosis case detected (microbiologically confirmed) to \'low\' despite most trials being well conducted. One of the main reasons for this downgrading was indirectness, as the findings of single trials are not easily generalized to other settings. As discussed above, effects will vary widely in line with local tuberculosis prevalence and local implementation.

We considered the certainty of evidence for the secondary outcome of long‐term tuberculosis prevalence to be \'very low\'. Again, this does not represent inadequacies in the conduct of the trial, but rather reflects the ongoing uncertainty about whether tuberculosis case‐finding interventions could reduce prevalence. We downgraded the single study for indirectness (as the findings are not easily generalized to other settings) and imprecision (as the level of statistical certainty does not exclude the possibility of important effects).

Potential biases in the review process {#CD011432-sec2-0014}
--------------------------------------

We minimized potential biases during the review process by adhering to the guidelines of the *Cochrane Handbook for Systematic Reviews of Interventions* ([@CD011432-bbs2-0086]) and the *Methodological Expectations of Cochrane Intervention Reviews* (MECIR) ([@CD011432-bbs2-0087]). We conducted a comprehensive search of all languages for both peer‐reviewed and grey literature. Two review authors independently assessed study eligibility, extracted data, and assessed the risk of bias in each included trial.

The findings of this review are based on the extensive and updated search of the studies done in high‐burden tuberculosis countries. The extensive risk of bias assessment was applied for both randomized and non‐randomized trials which helped to critically interpret the findings. The strength of the review is that it enables an assessment of various interventions applied either at the community or the primary healthcare setting to increase tuberculosis case detection. The limitations of the study include the following.

The diversity of interventions and low number of studies to make a good comparison and asses the level of evidence.There is also diversity of diagnostic tools with varying sensitivity such as smear microscopy and more sensitive molecular test like Gene Xpert MTB/RIF.The effect of the interventions on tuberculosis treatment outcome was limited because of the low number of tuberculosis patients.

Agreements and disagreements with other studies or reviews {#CD011432-sec2-0015}
----------------------------------------------------------

A previous systematic review by Kranzer and colleagues concentrated on the yield of tuberculosis cases achieved with various active case‐finding strategies ([@CD011432-bbs2-0089]). As such, they included both controlled studies (included here) and uncontrolled studies (which we excluded). The use of \'yield\' as an outcome, especially without a control group, has limitations, as it can be unclear whether these cases would have presented passively anyway. However, Kranzer and colleagues also note that people with tuberculosis identified through screening tended to be less sick, and have had the illness for less time, which is consistent with successfully identifying more cases.

[@CD011432-bbs2-0089] also had a wider scope, and included interventions within high‐risk communities such as prisons and clinics for people with HIV. They found that generally the yield was lowest with population screening, which may make population screening less attractive and affordable in many settings.

Authors\' conclusions {#CD011432-sec1-0007}
=====================

The available evidence demonstrates that when interventions are used in high‐burden settings, active case‐finding approaches may increase tuberculosis case detection in the short term in moderate‐ to high‐tuberculosis prevalence settings. However, it is unclear from the available evidence if active case‐finding interventions may improve treatment success and reduce tuberculosis treatment failure, mortality, and default.For the purposes of this review, we chose to only include controlled trials, as these most reliably demonstrate the true effects of any intervention, and will be most useful to decision‐makers designing local interventions. However, it is likely that many national or local decisions will be based upon uncontrolled pilot studies demonstrating an acceptable yield of tuberculosis cases (microbiologically confirmed) with an intervention that is deemed affordable, and that the implementation of the intervention will be periodically modified through monitoring and audit. This pragmatic approach is a perfectly reasonable form of evidence‐based decision‐making, and we hope that this summary of the global evidence base assists in those decisions. Further studies are being conducted to utilize GeneXpert Ultra (a more sensitive version of the Xpert MTB/RIF cartridge) as the first test for screening populations using active case finding. It is therefore likely that the pool of studies will increase in the near future.In the future there is a need to design and conduct trials employing appropriate case detection methods for children, in whom tuberculosis is an important cause of illness. The trials could include scoring systems for children using chest X‐rays, signs and symptoms, and results of tuberculin skin tests.
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**Search setEmbase**1Tuberculosis \[Emtree\]2Tuberculosis \[ti, ab\]3Mycobacterium tuberculosis \[Emtree\]4Case\* detection ti, ab5Case\* finding ti, ab6Systematic screening\* ti, ab7Case finding \[Emtree\]81 or 2 or 394 or 5 or 6 or 710Diagnos\* OR detect\* OR screen\* OR assess\* ti, ab118 and 9 and 10

**Search setMEDLINE**1tuberculosis \[MeSH\]2tuberculosis \[ti, ab \]3Mycobacterium tuberculosis \[MeSH\]4Case\* detection ti, ab5Case\* finding ti, ab6Systematic screening\* ti, ab71 or 2 or 384 or 5 or 69Diagnos\* OR detect\* OR screen\* OR assess\* ti, ab107 and 8 and 911‐

The Cochrane Library {#CD011432-sec3-0033}
====================

\#1 tuberculosis \#2 MeSH descriptor: \[Tuberculosis\] explode all trees \#3 MeSH descriptor: \[Mycobacterium tuberculosis\] explode all trees \#4 \#1 or \#2 or \#3 \#5 \"case detection\" or \"case finding\" or \"systematic screening\" \#6 \#4 and \#5

Web of Science Core Collection {#CD011432-sec3-0034}
==============================

You searched for: TOPIC: (tuberculosis) *AND* TOPIC: ((case finding) OR (case detection) OR (systematic screening)) *AND* TOPIC: (diagnos\* OR detect\* OR screen\* OR assess) *AND* TOPIC: (intervention\* OR program\* OR community OR random\* OR trial\* OR before) \...MoreTOPIC: (tuberculosis) *AND* TOPIC: ((case finding) OR (case detection) OR (systematic screening)) *AND* TOPIC: (diagnos\* OR detect\* OR screen\* OR assess) *AND* TOPIC: (intervention\* OR program\* OR community OR random\* OR trial\* OR before)

Indexes: SCI‐EXPANDED, SSCI,

BIOSIS Previews {#CD011432-sec3-0035}
===============

You searched for: TOPIC: (tuberculosis OR TB) *AND* TOPIC: ((case finding) OR (case detection) OR (systematic screening)) *AND* TOPIC: ((intervention\* OR program\* OR community OR random\* OR trial\* OR before)) \...More TOPIC:(tuberculosis OR TB) *AND* TOPIC:((case finding) OR (case detection) OR (systematic screening)) *AND* TOPIC: ((intervention\* OR program\* OR community OR random\* OR trial\* OR before))

Indexes: BIOSIS Previews.

Scopus {#CD011432-sec3-0036}
======

( TITLE‐ABS‐KEY ( tuberculosis ) AND TITLE‐ABS‐KEY ( ( case detection ) OR ( case finding ) OR ( systematic screening ) ) AND TITLE‐ABS‐KEY ( intervent\* OR program\* OR initiative OR trial\* OR random\* OR before ) ) AND SUBJAREA ( mult OR agri OR bioc OR immu OR neur OR phar OR mult OR medi OR nurs OR vete OR dent OR heal OR mult OR arts OR busi OR deci OR econ OR psyc OR soci ) AND ( LIMIT‐TO ( SUBJAREA , \"MEDI\" ) )

Comparison 1Outreach tuberculosis screening versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Tuberculosis cases detected (microbiologically confirmed)](#CD011432-fig-00101){ref-type="fig"}Analysis 1.1Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 1 Tuberculosis cases detected (microbiologically confirmed).4163043Risk Ratio (M‐H, Random, 95% CI)1.24 \[0.86, 1.79\][2 Tuberculosis cases detected: subgrouped by tuberculosis prevalence](#CD011432-fig-00102){ref-type="fig"}Analysis 1.2Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 2 Tuberculosis cases detected: subgrouped by tuberculosis prevalence.4163043Risk Ratio (M‐H, Fixed, 95% CI)1.16 \[0.92, 1.46\]2.1 Prevalence \< 5%17125Risk Ratio (M‐H, Fixed, 95% CI)0.85 \[0.60, 1.19\]2.2 Prevalence 5%+3155918Risk Ratio (M‐H, Fixed, 95% CI)1.52 \[1.10, 2.09\][3 Tuberculosis cases detected; subgrouped by intervention](#CD011432-fig-00103){ref-type="fig"}Analysis 1.3Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 3 Tuberculosis cases detected; subgrouped by intervention.4163043Risk Ratio (M‐H, Random, 95% CI)1.24 \[0.86, 1.79\]3.1 Outreach clinics plus health promotion152405Risk Ratio (M‐H, Random, 95% CI)1.28 \[0.76, 2.17\]3.2 House‐to‐house screening plus health promotion3110638Risk Ratio (M‐H, Random, 95% CI)1.25 \[0.75, 2.08\][4 Tuberculosis cases detected (all forms)](#CD011432-fig-00104){ref-type="fig"}Analysis 1.4Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 4 Tuberculosis cases detected (all forms).128704Risk Ratio (M‐H, Fixed, 95% CI)1.28 \[0.83, 1.98\][5 Tuberculosis treatment default](#CD011432-fig-00105){ref-type="fig"}Analysis 1.5Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 5 Tuberculosis treatment default.3849Risk Ratio (M‐H, Fixed, 95% CI)0.67 \[0.47, 0.96\][6 Tuberculosis treatment success](#CD011432-fig-00106){ref-type="fig"}Analysis 1.6Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 6 Tuberculosis treatment success.3849Risk Ratio (M‐H, Fixed, 95% CI)1.07 \[1.00, 1.15\][7 Tuberculosis treatment failure](#CD011432-fig-00107){ref-type="fig"}Analysis 1.7Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 7 Tuberculosis treatment failure.3849Risk Ratio (M‐H, Fixed, 95% CI)1.57 \[0.50, 4.92\][8 Tuberculosis mortality](#CD011432-fig-00108){ref-type="fig"}Analysis 1.8Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 8 Tuberculosis mortality.3849Risk Ratio (M‐H, Fixed, 95% CI)0.99 \[0.43, 2.25\][9 Long‐term tuberculosis prevalence](#CD011432-fig-00109){ref-type="fig"}Analysis 1.9Comparison 1 Outreach tuberculosis screening versus no intervention, Outcome 9 Long‐term tuberculosis prevalence.1Risk Ratio (Fixed, 95% CI)1.14 \[0.65, 2.00\]

Comparison 2Health promotion activities compared to no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Long‐term tuberculosis prevalence](#CD011432-fig-00201){ref-type="fig"}Analysis 2.1Comparison 2 Health promotion activities compared to no intervention, Outcome 1 Long‐term tuberculosis prevalence.1Risk Ratio (Fixed, 95% CI)Totals not selected

Comparison 3Training interventions compared to interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Tuberculosis cases detected (microbiologically confirmed)](#CD011432-fig-00301){ref-type="fig"}Analysis 3.1Comparison 3 Training interventions compared to intervention, Outcome 1 Tuberculosis cases detected (microbiologically confirmed).1Risk Ratio (M‐H, Random, 95% CI)Totals not selected

Comparison 4Outreach tuberculosis services versus health promotionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Tuberculosis cases detected (microbiologically confirmed)](#CD011432-fig-00401){ref-type="fig"}Analysis 4.1Comparison 4 Outreach tuberculosis services versus health promotion, Outcome 1 Tuberculosis cases detected (microbiologically confirmed).1Risk Ratio (Fixed, 95% CI)Totals not selected1.1 Adjusted for cluster design1Risk Ratio (Fixed, 95% CI)0.0 \[0.0, 0.0\]

Comparison 5Outreach clinic versus house‐to‐house screeningOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Tuberculosis cases detected (microbiologically confirmed)](#CD011432-fig-00501){ref-type="fig"}Analysis 5.1Comparison 5 Outreach clinic versus house‐to‐house screening, Outcome 1 Tuberculosis cases detected (microbiologically confirmed).1Risk Ratio (Random, 95% CI)Totals not selected1.1 Adjusted for cluster design1Risk Ratio (Random, 95% CI)0.0 \[0.0, 0.0\]

Comparison 6Active case‐finding interventions versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Tuberculosis cases detected (microbiologically confirmed)](#CD011432-fig-00601){ref-type="fig"}Analysis 6.1Comparison 6 Active case‐finding interventions versus no intervention, Outcome 1 Tuberculosis cases detected (microbiologically confirmed).5Risk Ratio (M‐H, Random, 95% CI)Subtotals only[2 Tuberculosis cases detected: subgrouped by tuberculosis prevalence](#CD011432-fig-00602){ref-type="fig"}Analysis 6.2Comparison 6 Active case‐finding interventions versus no intervention, Outcome 2 Tuberculosis cases detected: subgrouped by tuberculosis prevalence.5164532Risk Ratio (M‐H, Fixed, 95% CI)1.24 \[1.01, 1.53\]2.1 Prevalence \< 5%17125Risk Ratio (M‐H, Fixed, 95% CI)0.85 \[0.60, 1.19\]2.2 Prevalence 5%+4157407Risk Ratio (M‐H, Fixed, 95% CI)1.56 \[1.20, 2.04\][3 Tuberculosis cases detected; subgrouped by intervention](#CD011432-fig-00603){ref-type="fig"}Analysis 6.3Comparison 6 Active case‐finding interventions versus no intervention, Outcome 3 Tuberculosis cases detected; subgrouped by intervention.7Risk Ratio (Random, 95% CI)Subtotals only3.1 House‐to‐house screening plus health promotion3305698Risk Ratio (Random, 95% CI)1.30 \[0.84, 2.03\]3.2 Outreach tuberculosis diagnosis clinics plus health promotion2463323Risk Ratio (Random, 95% CI)1.43 \[1.11, 1.84\]3.3 Health promotion activities alone1405788Risk Ratio (Random, 95% CI)1.31 \[0.75, 2.29\]3.4 Health staff training in tuberculosis diagnosis11999Risk Ratio (Random, 95% CI)1.68 \[1.03, 2.73\][4 Long‐term tuberculosis prevalence: subgrouped by intervention](#CD011432-fig-00604){ref-type="fig"}Analysis 6.4Comparison 6 Active case‐finding interventions versus no intervention, Outcome 4 Long‐term tuberculosis prevalence: subgrouped by intervention.1Risk Ratio (Fixed, 95% CI)1.22 \[0.82, 1.82\]4.1 Contact tracing plus health promotion activities1Risk Ratio (Fixed, 95% CI)1.14 \[0.65, 2.00\]4.2 Health promotion activities alone1Risk Ratio (Fixed, 95% CI)1.31 \[0.75, 2.29\][5 Tuberculosis treatment success](#CD011432-fig-00605){ref-type="fig"}Analysis 6.5Comparison 6 Active case‐finding interventions versus no intervention, Outcome 5 Tuberculosis treatment success.3862Risk Ratio (M‐H, Random, 95% CI)1.07 \[1.00, 1.15\][6 Tuberculosis treatment default](#CD011432-fig-00606){ref-type="fig"}Analysis 6.6Comparison 6 Active case‐finding interventions versus no intervention, Outcome 6 Tuberculosis treatment default.43034Risk Ratio (M‐H, Random, 95% CI)0.62 \[0.47, 0.83\][7 Tuberculosis treatment failure](#CD011432-fig-00607){ref-type="fig"}Analysis 6.7Comparison 6 Active case‐finding interventions versus no intervention, Outcome 7 Tuberculosis treatment failure.3862Risk Ratio (M‐H, Random, 95% CI)1.62 \[0.50, 5.26\][8 Tuberculosis mortality](#CD011432-fig-00608){ref-type="fig"}Analysis 6.8Comparison 6 Active case‐finding interventions versus no intervention, Outcome 8 Tuberculosis mortality.3862Risk Ratio (M‐H, Random, 95% CI)0.99 \[0.43, 2.31\][9 People with tuberculosis detected](#CD011432-fig-00609){ref-type="fig"}Analysis 6.9Comparison 6 Active case‐finding interventions versus no intervention, Outcome 9 People with tuberculosis detected.3134339Risk Ratio (M‐H, Fixed, 95% CI)1.13 \[0.89, 1.44\]9.1 Prevalence \< 5%17125Risk Ratio (M‐H, Fixed, 95% CI)0.85 \[0.60, 1.19\]9.2 Prevalence 5%+2127214Risk Ratio (M‐H, Fixed, 95% CI)1.53 \[1.07, 2.19\]

Comparison 7Outreach tuberculosis services versus no intervention (sensitivity analyses)Outcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Tuberculosis cases detected (microbiologically confirmed)](#CD011432-fig-00701){ref-type="fig"}Analysis 7.1Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 1 Tuberculosis cases detected (microbiologically confirmed).4163043Risk Ratio (M‐H, Random, 95% CI)1.24 \[0.86, 1.79\][2 Tuberculosis cases detected: subgrouped by tuberculosis prevalence](#CD011432-fig-00702){ref-type="fig"}Analysis 7.2Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 2 Tuberculosis cases detected: subgrouped by tuberculosis prevalence.4163043Risk Ratio (M‐H, Fixed, 95% CI)1.16 \[0.92, 1.46\]2.1 Prevalence \< 5%17125Risk Ratio (M‐H, Fixed, 95% CI)0.85 \[0.60, 1.19\]2.2 Prevalence 5%+3155918Risk Ratio (M‐H, Fixed, 95% CI)1.52 \[1.10, 2.09\][3 Tuberculosis cases detected; subgrouped by intervention](#CD011432-fig-00703){ref-type="fig"}Analysis 7.3Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 3 Tuberculosis cases detected; subgrouped by intervention.4163043Risk Ratio (M‐H, Random, 95% CI)1.24 \[0.86, 1.79\]3.1 Outreach clinics plus health promotion152405Risk Ratio (M‐H, Random, 95% CI)1.28 \[0.76, 2.17\]3.2 House‐to‐house screening plus health promotion3110638Risk Ratio (M‐H, Random, 95% CI)1.25 \[0.75, 2.08\][4 Tuberculosis cases detected (all forms)](#CD011432-fig-00704){ref-type="fig"}Analysis 7.4Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 4 Tuberculosis cases detected (all forms).128704Risk Ratio (M‐H, Random, 95% CI)1.28 \[0.83, 1.98\][5 Tuberculosis treatment default](#CD011432-fig-00705){ref-type="fig"}Analysis 7.5Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 5 Tuberculosis treatment default.3Risk Ratio (M‐H, Fixed, 95% CI)Subtotals only5.1 Raw data3862Risk Ratio (M‐H, Fixed, 95% CI)0.68 \[0.48, 0.97\]5.2 Adjusted with ICC = 0.0013849Risk Ratio (M‐H, Fixed, 95% CI)0.67 \[0.47, 0.96\]5.3 Adjusted ICC = 0.00052 (Datiko)3855Risk Ratio (M‐H, Fixed, 95% CI)0.69 \[0.49, 0.98\][6 Tuberculosis treatment success](#CD011432-fig-00706){ref-type="fig"}Analysis 7.6Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 6 Tuberculosis treatment success.3Risk Ratio (M‐H, Fixed, 95% CI)Subtotals only6.1 Raw data3862Risk Ratio (M‐H, Fixed, 95% CI)1.07 \[1.00, 1.15\]6.2 Cluster adjusted: ICC = 0.0013849Risk Ratio (M‐H, Fixed, 95% CI)1.07 \[1.00, 1.15\][7 Tuberculosis treatment failure](#CD011432-fig-00707){ref-type="fig"}Analysis 7.7Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 7 Tuberculosis treatment failure.3Risk Ratio (M‐H, Random, 95% CI)Subtotals only7.1 Raw data3862Risk Ratio (M‐H, Random, 95% CI)1.62 \[0.50, 5.26\]7.2 Cluster adjusted: ICC = 0.0013849Risk Ratio (M‐H, Random, 95% CI)1.62 \[0.50, 5.26\][8 Tuberculosis mortality](#CD011432-fig-00708){ref-type="fig"}Analysis 7.8Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 8 Tuberculosis mortality.3Risk Ratio (M‐H, Fixed, 95% CI)Subtotals only8.1 Raw data3862Risk Ratio (M‐H, Fixed, 95% CI)0.99 \[0.43, 2.25\]8.2 Cluster adjusted: ICC = 0.0013849Risk Ratio (M‐H, Fixed, 95% CI)0.99 \[0.43, 2.25\][9 Long‐term tuberculosis prevalence](#CD011432-fig-00709){ref-type="fig"}Analysis 7.9Comparison 7 Outreach tuberculosis services versus no intervention (sensitivity analyses), Outcome 9 Long‐term tuberculosis prevalence.1Risk Ratio (Fixed, 95% CI)1.14 \[0.65, 2.00\]

The following are the changes between the protocol and the review.

We changed \"additional tuberculosis cases starting treatment\" to \"tuberculosis cases detected (all forms)\".We changed \"additional tuberculosis cases detected (microbiologically confirmed)\" to \"tuberculosis cases detected\".Primary outcome: We used \"tuberculosis cases detected (microbiologically confirmed)\" instead of \"tuberculosis cases detected (all forms)\" .

Characteristics of included studies \[ordered by study ID\] {#CD011432-sec2-0019}
===========================================================

[@CD011432-bbs2-0001]MethodsTrial design: A 2 X 2 factorial design cluster‐RCT\
Unit of randomization: Community ‐ average size 40110\
Number of clusters per study arm: 6\
Length of follow‐up: 54 months\
Adjusted for cluster design: YesParticipantsTarget group: adults 18 years of age or older.\
Total population of intervention areas: 962,655\
Total number of people screened for tuberculosis: 64643\
Exclusions: none\
Tuberculosis screening test: Symptoms in contact tracing, sputum smear in health promotion\
Tuberculosis diagnostic test: Sputum smear microscopy and mycobacterial cultureInterventions**Intervention area 1: Strengthened tuberculosis‐HIV programme plus health promotion**\
Did they look for TB cases outside of health facilities? NoDid they use health promotion strategies to encourage people to attend diagnostic services? Yes, through extensive promotion activities people were encouraged to drop sputum samples at central collection points.Did they train health workers in TB diagnosis? Yes, the TB‐HIV programme was strengthened at all clinics.\
**Intervention area 2: Strengthened tuberculosis‐HIV programme plus contact tracing**\
Did they look for TB cases outside of health facilities? Yes, household contacts of people diagnosed with TB were screened.Did they use health promotion strategies to encourage people to attend diagnostic services? No.Did they train health workers in TB diagnosis? Yes, the TB‐HIV programme was strengthened at all clinics.\
**Intervention area 3: A combination of 1 + 2**\
Did they look for TB cases outside of health facilities? Yes, household contacts of people diagnosed with TB were screened.Did they use health promotion strategies to encourage people to attend diagnostic services? Yes, through extensive promotion activities people were encouraged to drop sputum samples at central collection points.Did they train health workers in TB diagnosis? Yes, the TB‐HIV programme was strengthened at all clinics.\
**Control: Strengthened tuberculosis‐HIV programme at the clinics only**Outcomes**Outcomes included in the review**\
Additional tuberculosis cases detectedCommunity tuberculosis prevalence at 3.5 to 4.5 years postinterventionNotesCountries: Zambia and South Africa\
Setting: Rural and urban Zambia and Western Cape in South Africa\
Tuberculosis prevalence: 832 per 100,000 population\
HIV prevalence: Zambia: 15.9% to 18.0%, South Africa: 16.9% to 19.2%\
Study dates: 1 August 2006 to 31 July 2009\
Study sponsor: Bill & Melinda Gates Foundation***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Randomization of intervention was stratified by country and the prevalence of tuberculous infection. Additionally randomization was restricted to ensure balance of prevalence of tuberculosis infection, HIV prevalence, urban and rural location, social context and geographical location. A list of 1000 possible allocations of communities to four groups was drawn as a random sample from a total of about 7 million allocations that met restriction criteria.\"Allocation concealment (selection bias)Low riskQuote: \"A two stage public randomization ceremony was done, first to select one of the 1000 possible allocations of the 24 communities into four groups, and second to allocate each of the four trial groups to one of the letters A, B, C, D\"Blinding of participants and personnel (performance bias) All outcomesLow riskComment: Neither participants nor study personnel were blinded to the intervention group, but this is unlikely to bias the result separately from the effect of the intervention.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote: "Analysis of sputum samples collected in the prevalence survey was done blinded to group assignment\"Incomplete outcome data (attrition bias) All outcomesLow riskComment: no loss of clusters occurred. A large number of samples were either missing (2330), failed to meet predefined quality standards (18,101), or were contaminated (5707). However, the proportions were reasonably balanced across groups.Selective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Similar characteristics (low risk)\
Loss of clusters: Low risk\
Incorrect analysis: Primary outcome adjusted for clustering.\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0002]MethodsTrial design: cluster‐RCT Unit of randomization: farm ‐ median size 44 adult farm workers Number of clusters per study arm: 106 intervention vs 105 control\
Length of follow‐up: 6 months Adjusted for cluster design: yesParticipantsTarget population: adults aged \> 15 years Total population of intervention areas: 4438 (adults)\
Total number of people screened for tuberculosis in intervention areas: not stated Exclusion criteria: multidrug‐resistant tuberculosis patients\
Tuberculosis screening test: symptom screen ‐ criteria not defined\
Tuberculosis diagnostic test: sputum smear microscopy x 2Interventions**Intervention areas**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, lay health workers screened all farm dwellers monthly and referred to tuberculosis centres.Were there health promotion activities to encourage people to attend diagnostic services? No.Were health workers trained in tuberculosis diagnosis? Yes, lay health workers had 5 weeks of training on tuberculosis, family health, HIV, first aid, and home‐based care.\
**Control areas**\
No interventionOutcomes**Outcomes included in the review**\
Tuberculosis cases detectedTreatment completionTuberculosis cureTuberculosis mortalityNotesCountry: South Africa Setting: Rural Tuberculosis prevalence: Not stated\
HIV prevalence: Not stated Study dates: May 2000 to Sept 2000 Study sponsors: Boland District Municipality, The Medical Research Council of South Africa, UK Department of International Development***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: "All the numbers were randomly drawn from containers and allocated sequentially to the intervention or control group"Allocation concealment (selection bias)Low riskComment: None described but cluster‐randomized studies are generally at low risk of selection bias if the sequence generation is low risk.Blinding of participants and personnel (performance bias) All outcomesLow riskComment: None described, however this is unlikely to bias the result.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: None describedIncomplete outcome data (attrition bias) All outcomesLow riskComment: No loss of clusters. A small number of people diagnosed with tuberculosis transferred out.Selective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Similar characteristics (low risk)\
Loss of clusters: No loss of cluster (low risk)\
Incorrect analysis: Primary outcome not adjusted for clustering (low risk).\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0003]MethodsTrial design: Cluster‐randomized trial\
Unit of randomization: Areas of residential suburbs ‐ approximate size 2000 to 3000 adults\
Number of clusters per study arm: 23\
Length of follow‐up: 35 months\
Adjusted for cluster design: YesParticipantsTarget group: Adults aged 16 years or older\
Total population of intervention areas: Mobile van: 55,741 vs door‐to‐door: 54,691\
Total number of people screened for tuberculosis: Mobile van: 5466 vs door‐to‐door: 4711\
Exclusions: None\
Tuberculosis screening test: Symptom screen ‐ cough \> 2 weeks\
Tuberculosis diagnostic test: Sputum smear, mycobacteria culture, chest X‐rayInterventions**Intervention area 1: Mobile van**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, a mobile van was located in each cluster for 5 days in each of 6 rounds.Were there health promotion activities to encourage people to attend diagnostic services? Yes, a loudspeaker and leafleting encouraged people to attend.Were health workers trained in tuberculosis diagnosis? Yes, the tuberculosis‐HIV programme was strengthened at all clinics.\
**Intervention area 2: Door‐to‐door screening**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, all households were visited up to 3 times in each of 6 rounds by 2 teams of 3 lay field workers.Were there health promotion activities to encourage people to attend diagnostic services? No.Were health workers trained in tuberculosis diagnosis? Unclear, improvements in the skills of staff at the health clinics were not described.Outcomes**Outcomes included in the review**\
Additional tuberculosis cases detectedPrevalence of tuberculosis after the interventionNotesCountry: Zimbabwe\
Setting: Residential suburbs in Harare\
Tuberculosis prevalence: Smear‐positive 280 per 100,000 population\
HIV prevalence: 21% to 22%\
Study dates: January 2006 to November 2008\
Study sponsor: Wellcome Trust***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Randomisation was done by selection of red and black coloured discs (23 of each colour), which were otherwise identical, from an opaque bag held above eye‐level.\"Allocation concealment (selection bias)Low riskQuote: \"Discs were withdrawn at a public meeting by community advisory board members representing each cluster. Before selection began, black was allocated to represent the door‐to‐door group, and red to represent the mobile van group\"Blinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"Community health workers and cluster residents were not masked to the intervention\"\
Comment: This is unlikely to bias the result separately from the effect of the intervention.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Laboratory work and clinical management was done without reference to the intervention group, and interim data were not analysed by intervention group until the final analysis, allowing investigators and laboratory staff to be masked to intervention allocation\"Incomplete outcome data (attrition bias) All outcomesUnclear riskComment: Consent to participate in prevalence surveys was lower in men (57% to 65%) than in women (97% to 98%). The number of missing or contaminated sputum samples was not reported.Selective reporting (reporting bias)Low riskComment: No evidence of selective outcomes reportingOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Similar characteristics (low risk)\
Loss of clusters: None (low risk)\
Incorrect analysis: Primary outcome adjusted for clustering (low risk)\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0004]MethodsTrial design: Community‐randomized trial\
Unit of randomization: Kebele (lowest administrative unit) ‐ approximate size 5000 people\
Number of clusters per study arm: 31 intervention versus 21 control\
Length of follow‐up: 19 months\
Adjusted for cluster design: YesParticipantsTarget group: All ages\
Total population of intervention areas: 178,138\
Total number of people screened for tuberculosis: Not stated\
Exclusions: None mentioned\
Tuberculosis screening test: Cough for more than 2 weeks\
Tuberculosis diagnostic test: Sputum smear microscopy +/‐ CXRInterventions**Intervention areas: Training of health extension workers to visit houses and screen for tuberculosis.**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, health extension workers visited all households in the kebeles.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, health extension workers conducted health education sessions at health posts.Were health workers trained in tuberculosis diagnosis? Yes, health extension workers were trained to screen for chronic cough and collect, store, and transport sputum samples.\
**Control areas: No intervention**\
Health extension workers did not receive training, but provided health services including health education about tuberculosis the people living in their kebeles.Outcomes**Outcomes included in the review**\
Additional tuberculosis cases detectedTuberculosis cureTreatment completionEarly default (prior to commencing treatment or during the intensive phase of treatment)Tuberculosis mortalityNotesCountry: Ethiopia\
Setting: Rural districts of Sidama zone in Southern Ethiopia\
Tuberculosis prevalence: 122 per 100,000 population\
HIV prevalence: HIV test was not done and kits were not available during the study\
Study dates: September 2006 to April 2008\
Study sponsor: The University of Bergen***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"We used the list of kebeles in the two districts and randomly allocated them to intervention and control groups using a table of random numbers.\"Allocation concealment (selection bias)Low riskComment: Allocation concealment was not described, however cluster‐randomized studies are generally considered to be at low risk of bias for allocation concealment, as allocation takes place centrally.Blinding of participants and personnel (performance bias) All outcomesLow riskComment: Participants and personnel were not blinded. However, given the nature of the intervention, this was unlikely to introduce bias into the results.Blinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"Although we did not blind the laboratory technicians, they were not informed whether the sputum specimens were from intervention or control kebels.\"Incomplete outcome data (attrition bias) All outcomesLow riskComment: There was no loss of clusters. 3/88 tuberculosis‐positive patients were transferred out in the control group vs 0/230 in the intervention group. The number of sputum samples lost or contaminated was not reported.Selective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Similar characteristics (low risk)\
Loss of clusters: None (low risk)\
Incorrect analysis: Primary outcome adjusted for clustering (low risk)\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0005]MethodsTrial design: Cluster‐RCT\
Unit of randomization: Primary care clinics ‐ approximately 200 consultations per day\
Number of clusters per study arm: 20\
Length of follow‐up: 3 months\
Adjusted for cluster design: YesParticipantsTarget group: Aged 15 years and older\
Total population of intervention areas: Not stated\
Total number of people screened for tuberculosis in intervention areas: 1006\
Exclusions: People referred urgently elsewhere\
Tuberculosis screening test: Symptom screen: criteria not described\
Tuberculosis diagnostic test: Sputum microscopy and mycobacteria cultureInterventions**Intervention clinics: Training nurse practitioners in tuberculosis diagnosis**\
Did health workers look for tuberculosis cases outside of health facilities? No.Were there health promotion activities to encourage people with symptoms to attend health services? No.Were health workers trained in tuberculosis diagnosis? Yes, nurse practitioners received between 2 and 6 educational sessions.\
**Control clinics**\
No interventionOutcomes**Outcomes included in the review**\
Addional tuberculosis cases detectedNotesCountry: South Africa\
Setting: Urban and rural clinics at The Free State province\
Tuberculosis prevalence: 494 per 100,000 population\
HIV prevalence: 30.1%\
Study dates: May to November 2013\
Study sponsor: International Development Research Centre, Canada, The South African Medical Council, the Free State Department of Health, and the University of Cape Town Lung Institute***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Clinics were ranked by size and allocated to intervention or control arms using a random number table in blocks of four"Allocation concealment (selection bias)Low riskOuote: \"Allocation was carried out by a trial statisticians before intervention or patient recruitment\"Blinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"Patients and field workers were blind to the intervention status of each clinic\"Blinding of outcome assessment (detection bias) All outcomesLow riskComment: Field workers screened all eligible participants leaving the clinics (after they had seen the nurse). The field workers were blind to whether the nurse had received the training or not.Incomplete outcome data (attrition bias) All outcomesLow riskComment: Loss to follow‐up of 7%. The number of lost or missing sputum samples was not reported.Selective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Similar characteristics (low risk)\
Loss of clusters: Unclear risk\
Incorrect analysis: Outcomes adjusted for clustering.\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0006]MethodsTrial design: Controlled before‐and‐after study Intervention area: Cali, capital city of Valle del Cauca, Colombia\
Control area: Riseralda, an area bordering Valle del Cauca\
Length of follow‐up: 2 yearsParticipantsTarget group: All ages Total population of intervention area: 2 million Total number of people screened for tuberculosis: 67,168 had smear microscopy. Exclusions: None stated.\
Tuberculosis screening test: None stated.\
Tuberculosis diagnostic test: Sputum smear microscopyInterventions**Intervention clinics: Mass media tuberculosis health promotion**\
Did health workers look for tuberculosis cases outside of health facilities? No.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, a mass media campaign using television and radio public service announcements and chat shows, and newspaper flyers and feature articles.Were health workers trained in tuberculosis diagnosis? Yes, but no details given and no different from control areas.\
**Control group**\
No interventionOutcomes**Outcomes included in the review**\
Tuberculosis cases detectedNotesCountry: Colombia Setting: Urban Tuberculosis prevalence: 35 per 100,000 population\
HIV prevalence: Not stated Study dates: January 1993 to January 1995 Study sponsors: Not stated***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskComment: Non‐randomizedAllocation concealment (selection bias)High riskComment: Non‐randomizedBlinding of participants and personnel (performance bias) All outcomesLow riskComment: Blinding was not done but this was unlikely to bias the result.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: None described.Incomplete outcome data (attrition bias) All outcomesUnclear riskComment: No losses described.Selective reporting (reporting bias)Low riskComment: No evidence of selective outcome reportingOther biasLow risk**[ROBINS‐I bias domains]{.ul}**\
Confounding: No confounding expected (low risk).\
Selection of participants: All eligible participants were included (low risk).\
Classification of interventions: The assignment of the interventions was determined retrospectively (moderate risk).\
Deviations from intended interventions: \"the sources used by the campaign made it likely that a substantial proportion of the population of the whole department of Valle had been was exposed to the media campaign\" (moderate risk)\
Missing data: Data were reasonably complete (low risk).\
Measurement of outcomes: The outcome measure was unlikely to be influenced by the knowledge of the intervention (low risk).\
Selection of reported results: None (low risk)[@CD011432-bbs2-0007]MethodsTrial design: Non‐RCT (retrospective review of records)\
Intervention area: 7 out of 10 districts where the intervention was implemented\
Control area: 7 districts chosen on the basis of size and population\
Length of follow‐up: 1 yearParticipantsTarget group: Children aged 0 to 14 years\
Total population of intervention area: Approximately 1,489,785 children\
Total number of people screened for tuberculosis in intervention area: 16,740\
Exclusions: None stated.\
Tuberculosis screening test: Symptom screening\
Tuberculosis diagnostic test: Sputum smear microscopy for AFB, chest radiography, and tuberculin skin testInterventions**Intervention areas**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, household contact tracing, mobile chest camps in hard‐to‐reach areas, home visits for children with HIV, and screening at schools and safe motherhood clinicsWere there health promotion activities to encourage people with symptoms to attend health services? Yes, through safe motherhood servicesWere health workers trained in tuberculosis diagnosis? Not described\
**Control areas**\
No interventionOutcomes**Outcomes included in the review**\
Additional tuberculosis casesChange in case registration rate per 100,000NotesCountry: Nepal\
Setting: Not specified\
Tuberculosis prevalence: Not stated\
HIV prevalence: Not stated\
Study dates: March 2013 to March 2014\
Study sponsor: The Union (Paris, France), MSF (Brussels Operational Centre, Luxembourg), the Department for International Development (UK), and the World Health Organization.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskComment: Not randomizedAllocation concealment (selection bias)High riskComment: Not randomizedBlinding of participants and personnel (performance bias) All outcomesLow riskComment: No blinding of participants and healthcare workers, however there is low risk of this causing any bias.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: Not describedIncomplete outcome data (attrition bias) All outcomesUnclear riskComment: Not describedSelective reporting (reporting bias)Low riskComment: No evidence of selective outcome reportingOther biasHigh risk[**ROBINS‐I bias domains**]{.ul}\
Confounding: Residual confounding of the population prognostic factors that determined the intervention (serious risk).\
Selection of participants: \"the intervention districts were selected on the basis of poverty, higher population density and lower notification rates of childhood TB case finding\" (serious risk)\
Classification of interventions: The assignment of the interventions was determined retrospectively for (moderate risk).\
Deviations from intended interventions: No deviations from the interventions (low risk)\
Missing data: Data were reasonably complete (low risk).\
Measurement of outcomes: The outcome measure was unlikely to be influenced by the knowledge of the intervention (low risk).\
Selection of reported results: None (low risk)[@CD011432-bbs2-0008]MethodsTrial design: Non‐RCT\
Intervention area: A section of Karachi, Pakistan (lower‐income households)\
Control area: An adjacent section of Karachi\
Length of follow‐up: 12 monthsParticipantsTarget group: All ages\
Total population of intervention area: 915,767\
Total number of people screened for tuberculosis in intervention area: 469,896\
Exclusions: None\
Tuberculosis screening test: Cough for \> 3 weeks or productive cough for \> 2 weeks\
Tuberculosis diagnostic test: Sputum smear, GeneXpert, or chest X‐rayInterventions**Intervention areas: Health promotion and screening at health centres**\
Did health workers look for tuberculosis cases outside of health facilities? No, lay people were trained to screen patients at family clinics and outpatient departments.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, billboards, cable television advertisements, posters, flyers.Were health workers trained in tuberculosis diagnosis? Yes, screeners were trained on tuberculosis awareness and screening.Other activities? Screeners received financial incentives and were supervised by experienced community health workers.\
**Control areas**\
No interventionOutcomes**Outcomes included in the review**\
Additional tuberculosis casesEarly default (prior to commencing treatment or during the intensive phase of treatment)Tuberculosis cureTreatment completionTuberculosis mortalityNotesCountry: Pakistan\
Setting: Primary healthcare clinics (family clinics) and outpatient departments in Karachi\
Tuberculosis prevalence: 364 per 100,000 population\
HIV prevalence: Not reported\
Study dates: 3 January 2010 to 31 December 2011\
Study sponsor: TB REACH initiative of the Stop TB Partnership***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskComment: Not randomized, so susceptible to confounding by siteAllocation concealment (selection bias)High riskComment: Not randomized, so susceptible to confounding by siteBlinding of participants and personnel (performance bias) All outcomesLow riskComment: No blinding of patients or health workers. However, this was unlikely to bias the result.Blinding of outcome assessment (detection bias) All outcomesLow riskComment: Similar assessment of the outcomes retrospectively by the tuberculosis programme investigators with no blindingIncomplete outcome data (attrition bias) All outcomesUnclear riskComment: No comment on missing outcome dataSelective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow risk**[ROBINS‐I bias domains]{.ul}**\
Confounding: No confounding (low risk)\
Selection of participants: All eligible study participants were included in the study (low risk).\
Classification of interventions: Intervention status was well defined (low risk).\
Deviations from intended interventions: \"Because several components were implemented simultaneously, we are unable to determine which one contributed most to the observed effect, and whether any one of the components in isolation would have had a substantial effect\" (moderate risk)\
Missing data: None reported (low risk).\
Measurement of outcomes: Assessment of the outcome was comparable across the groups (low risk).\
Selection of reported results: No selective reporting (low risk)[@CD011432-bbs2-0009]MethodsTrial design: Quasi‐experimental exploratory study\
Intervention area: Punjab province in Pakistan\
Control area: 8 control districts\
Length of follow‐up: 9 monthsParticipantsTarget group: All ages\
Total population of intervention area: 662,249\
Total number of people screened for tuberculosis in intervention area: 662,249\
Exclusions: None\
Tuberculosis screening test: Tuberculosis symptom screening\
Tuberculosis diagnostic test: Sputum smear microscopyInterventions**Intervention areas: Health promotion and screening at health centres**\
Where healthcare workers trained in tuberculosis management and diagnosis? Yes, 1) joint review of the participating facilities, reviewing the input availability, case management practices and indicator analysis of respective facilities, and 2) progress review and action plan of the diagnostic centreOther activities? Developing the intervention monitoring guidelines and tools, which was done using a technical working group process that involved the national tuberculosis control programme\
**Control areas: No intervention**Outcomes**Outcomes included in the review**\
Additional tuberculosis cases detected (microbiologically confirmed)Early default (prior to commencing treatment)NotesCountry: Pakistan\
Setting: Outpatient departments in Punjab\
Tuberculosis prevalence: Not mentioned\
HIV prevalence: Not mentioned\
Study dates: April 2007 to January 2008\
Study sponsor: UK aid***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskComment: Not randomized, so susceptible to confounding by siteAllocation concealment (selection bias)High riskComment: Not randomized, so susceptible to confounding by siteBlinding of participants and personnel (performance bias) All outcomesLow riskComment: Neither patients nor healthcare workers were blinded.Blinding of outcome assessment (detection bias) All outcomesLow riskComment: Outcomes were assessed retrospectively by the district tuberculosis co‐ordinators with no blinding.Incomplete outcome data (attrition bias) All outcomesUnclear riskComment: No comment on missing dataSelective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow risk**[ROBINS‐I bias domains]{.ul}**\
Confounding: No confounding expected (low risk)\
Selection of participants: Moderate bias as district health officers who did not agree to participate in the study were excluded (moderate risk).\
Classification of interventions: The interventions are well defined (low risk).\
Deviations from intended interventions: No deviations from the interventions (low risk)\
Missing data: Data were reasonably complete (low risk).\
Measurement of outcomes: The outcome measure could be influenced by knowledge of the intervention study participants received (moderate risk).\
Selection of reported results: None (low risk)[@CD011432-bbs2-0010]MethodsTrial design: Cluster‐RCT\
Unit of randomization: Neighbourhoods\
Number of clusters per study arm: 7 (total 15 clusters including 1 control)\
Length of follow‐up: 283 days\
Adjusted for cluster design: Yes\
Study areas: A large favela in Rio de Janeiro, BrazilParticipantsTarget group: Adults aged \> 18 years\
Sample size: 58,587\
Exclusions: None described.\
Tuberculosis screening test: Cough for \> 3 weeks (as part of a 7‐question tuberculosis symptom survey)\
Tuberculosis diagnostic test: Sputum sample x 2 for microscopy + abnormal CXRInterventions**Intervention 1: Door‐to‐door screening**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, community health agents visited all households to conduct a symptom screen and collect a sputum sample when indicated.Were there health promotion activities to encourage people with symptoms to attend health services? A national television tuberculosis awareness campaign is described.Were health workers trained in tuberculosis diagnosis? No specific training is described.Other activities? No other activities\
**Intervention 2: Informational pamphlet**\
Did health workers look for tuberculosis cases outside of health facilities? No.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, an informational pamphlet was delivered to each household describing the symptoms of tuberculosis and encouraging attendance at local health clinics for free care.Were health workers trained in tuberculosis diagnosis? No specific training is described.Other activities? NoneOutcomes**Outcomes included in the review**\
Additional tuberculosis casesTime to diagnosisTreatment completionNotesCountry: Brazil\
Setting: Urban slums\
Tuberculosis incidence: 565 per 100,000 population\
HIV prevalence: not stated\
Study dates: 2005 to 2006\
Study sponsor: United States Agency for International Development and National Institutes of Health grants***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskComment: \"14 neighbourhoods were matched into seven pairs with similar 2004 case notification rates using a constrained randomization scheme with a relative difference of 5% between marginal rates. One of these permutations was selected at random using MS Excel's RAND command (MicroSoft, Redmond, WA, USA).\"Allocation concealment (selection bias)Unclear riskComment: None described.Blinding of participants and personnel (performance bias) All outcomesUnclear riskComment: None described.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: None described.Incomplete outcome data (attrition bias) All outcomesUnclear riskComment: None described.Selective reporting (reporting bias)Low riskComment: No evidence of selective outcome reportingOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Matched study with similar characteristics (low risk)\
Loss of clusters: Low risk\
Incorrect analysis: Primary outcome not adjusted for clustering, Cochrane Review adjusts for this (low risk).\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0011]MethodsTrial design: Quasi‐experimental cluster‐randomized trial\
Unit of randomization: Operational district (OD) with estimated population of 100,000 to 200,000\
Number of clusters per study arm: 15 ODs\
Length of follow‐up: 1 year\
Study areas: Cambodia, selected 30 of the 71 ODs.ParticipantsTarget group: All ages\
Target population in the intervention: 2.9 million people\
Exclusions: None\
Tuberculosis screening test: Tuberculosis symptoms screening (cough, fever, weight loss, and/or night sweats of more than 2 weeks)\
Tuberculosis diagnostic test: CXR, clinical diagnosis, and Gene Xpert/MTB RIFInterventions**Intervention: House‐to‐house visits**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, trained healthcare workers and community volunteers conducted house‐to‐house visits.\
**Group 2: No intervention**\
Tuberculosis was diagnosed as per national guidelines of self referral patients.Outcomes**Outcomes included in the review**\
Additional tuberculosis cases starting treatmentAdditonal tuberculosis cases detected (microbiologically confirmed)NotesCountry: Cambodia\
Setting: Urban/rural\
Tuberculosis incidence: 715 people with tuberculosis per 100,000 population\
HIV prevalence: Not mentioned\
Study dates: Year 1, February to December 2012; Year 2, May 2013 to March 2014\
Study sponsor: Government of Japan through Ministry of Health, Labour and Welfare and Korean Centers for Disease Control and Prevention, Republic of Korea***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskComment: \"These 30 ODs were randomly allocated into intervention and control groups\"Allocation concealment (selection bias)Low riskComment: Allocation concealment was not described, however cluster‐randomized studies are generally considered to be at low risk of bias for allocation concealment as allocation takes place centrally.Blinding of participants and personnel (performance bias) All outcomesLow riskComment: Participants and personnel were not blinded. However, given the nature of the intervention, this was unlikely to introduce bias into the results.Blinding of outcome assessment (detection bias) All outcomesLow riskComment: No blinding was done. However, the outcome measurement was unlikely to be biased due to the need for bacteriological confirmation. Also, diagnosis of bacteriologically negative tuberculosis and extra‐pulmonary tuberculosis was made by clinicians based on all available evidence on the same day of the active case finding.Incomplete outcome data (attrition bias) All outcomesUnclear riskComment: Not describedSelective reporting (reporting bias)Unclear riskComment: Not describedOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Not reported (unclear risk)\
Loss of clusters: None (low risk)\
Incorrect analysis: Primary outcome not adjusted for clustering, Cochrane Review adjusts for this (low risk).\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0012]MethodsTrial design: Individually randomized controlled trial\
Study areas: Cape Winelands District of South Africa\
Length of follow‐up: 2 yearsParticipantsTarget group: BCG vaccinated infants\
Sample size: 4786\
Exclusions: None described.\
Tuberculosis screening test: Tuberculosis contact or cough/fever/weight loss or loss of appetite for \> 2 weeks\
tuberculosis diagnostic test: CXR, tuberculin test, early morning gastric washing, induced sputum, smear microscopy and cultureInterventions**Intervention: Home visits and record surveillance**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, infants were visited at home every 3 months.Were there health promotion activities to encourage people with symptoms to attend health services? No.Were health workers trained in tuberculosis diagnosis? Unclear ‐ not describedOther activities? Surveillance of tuberculosis records, hospital admission lists and records, surveillance of clinical and hospital X‐rays\
**Group 2: Record surveillance only**\
Surveillance of tuberculosis records, hospital admission lists and records, surveillance of clinical and hospital X‐raysOutcomes**Outcomes included in the review**\
Additional tuberculosis casesMortalityNotesCountry: South Africa\
Setting: Rural\
Tuberculosis incidence: 1442 per 100,000 population\
HIV prevalence: Antenatal HIV prevalence of 12.8% in 2007\
Study dates: 2005 to 2008\
Study sponsor: Aeras Global TB Vaccine Foundation, Rockville, MD, USA***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Infants were randomised in a 1:1 ratio to Group 1 or Group 2 case finding using simple random allocation. These were assigned from a pre‐generated randomisation list\"Allocation concealment (selection bias)Low riskQuote: \"After obtaining consent from a parent or legal guardian, field workers telephoned the study administrator for the infant's randomisation group and study number\"Blinding of participants and personnel (performance bias) All outcomesLow riskComment: Participants and health workers were not blinded to study group. However, this was unlikely to have biased the outcomes.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"CXRs were reviewed independently by a panel of three paediatric radiologists who were blinded to the clinical information\"Incomplete outcome data (attrition bias) All outcomesLow riskComment: Moderate losses to follow‐up but evenly spread across groups: 14.7% intervention versus 15.3% control group.Selective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow riskComment: None noted.[@CD011432-bbs2-0013]MethodsTrial design: Prospective controlled before‐and‐after study\
Intervention area: 6 states of Southern Nigeria\
Control area: 6 states matched by \"in most respects\"\
Length of follow‐up: 1 yearParticipantsTarget group: Children aged less than 15 years\
Total population of intervention area: 14,742,185 children\
Total number of people screened for tuberculosis in intervention area: 36,214 children\
Exclusions: None stated.\
Tuberculosis screening test: A symptom screen\
Tuberculosis diagnostic test: Sputum smear, Keith Edwards child tuberculosis scoreInterventions**Intervention areas**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, screening of home contactsWere there health promotion activities to encourage people with symptoms to attend health services? Yes, 6000 handbills were distributed in hospitals, schools, and homes; 1500 posters were distributed to communities, schools, and health facilities; and there were 20 visits to primary schools to provide education.Were health workers trained in tuberculosis diagnosis? Yes, 120 medical officers and 150 nurses were trained in diagnosis and using job aids.Other activities? 5000 units of PPD were distributed. Screening was also conducted at outpatient clinics and ART clinics.\
**Control areas**\
No interventionOutcomes**Outcomes included in the review**\
Additional tuberculosis cases in the intervention areas. Data from the control areas were not presented.NotesCountry: Nigeria\
Setting: Not specified\
Tuberculosis prevalence: Not stated\
HIV prevalence: Not stated\
Study dates: 1 July 2013 to 30 June 2014\
Study sponsor: Canadian International Development Agency***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskComment: Not randomizedAllocation concealment (selection bias)High riskComment: Not randomizedBlinding of participants and personnel (performance bias) All outcomesLow riskComment: Participants and personnel were not blinded, however there was a low risk of bias.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: Not describedIncomplete outcome data (attrition bias) All outcomesUnclear riskComment: Not describedSelective reporting (reporting bias)Unclear riskComment: Tuberculosis cases detected in the control areas were not clearly reported.Other biasLow risk**[ROBINS‐I bias domains]{.ul}**\
Confounding: None expected (low risk).\
Selection of participants: All eligible participants were included (low risk).\
Classification of interventions: Facilities with highest number of children were purposefully selected (moderate risk).\
Deviations from intended interventions: Some of the interventions were not noted, though their impact is limited (moderate risk).\
Missing data: Expected to have similar missing data (low risk)\
Measurement of outcomes: The outcome measure could be minimally influenced by knowledge of the intervention (moderate risk).\
Selection of reported results: None (low risk)[@CD011432-bbs2-0014]MethodsTrial design: Controlled before‐and‐after study\
Intervention area: 20 designated microscopy centres (which serve vulnerable populations)\
Control area: 11 designated microscopy centres (which serve less vulnerable populations)\
Length of follow‐up: 6 monthsParticipantsTarget group: Adults and children from vulnerable communities\
Total population of intervention area: Approximately 2 million\
Total number of people screened for tuberculosis in intervention area: 8468/115,119 households were visited.\
Exclusions: None stated.\
Tuberculosis screening test: \"presumptive\" ‐ probably clinical criteria\
Tuberculosis diagnostic test: Sputum smearInterventions**Intervention areas**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, trained community volunteers visited the homes of people in vulnerable communities.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, information, education, and communication materials were given to each visited house.Were health workers trained in tuberculosis diagnosis? Yes, volunteers described as \"trained\".\
**Control areas**\
Standard facility‐based careOutcomes**Outcomes included in the review**\
Additional tuberculosis cases detectedNotesCountry: India\
Setting: 2 districts of Karnataka in Southern India\
Tuberculosis prevalence: Not stated\
HIV prevalence: Not stated\
Study dates: July to December 2013 compared to July to December 2012\
Study sponsor: United States Agency for International Development (USAID)***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskComment: Non‐randomized trialAllocation concealment (selection bias)High riskComment: Non‐randomized trialBlinding of participants and personnel (performance bias) All outcomesLow riskComment: Participants and personnel were not blinded, however there was a low risk of bias.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: Not describedIncomplete outcome data (attrition bias) All outcomesUnclear riskComment: Not describedSelective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow risk**[ROBINS‐I bias domains]{.ul}**\
Confounding: Confounding expected (moderate risk).\
Selection of participants: Selected population that was vulnerable (moderate risk)\
Classification of interventions: The interventions were determined retrospectively (moderate risk).\
Deviations from intended interventions: None expected (low risk).\
Missing data: Not documented (low risk)\
Measurement of outcomes: Minimal errors related to outcome (moderate risk)\
Selection of reported results: None (low risk)[@CD011432-bbs2-0015]MethodsTrial design: Cluster‐RCT\
Unit of randomization: Rural communities ‐ approximate size 11,000 people\
Number of clusters per study group: 12 intervention versus 20 control\
Length of follow‐up: 6 months\
Adjusted for cluster design: YesParticipantsTarget group: All ages\
Total population of intervention areas: 127,607\
Total number of people screened for tuberculosis in intervention area: Not stated\
Exclusions: None stated.\
Tuberculosis screening test: Symptom screening; criteria not described\
Tuberculosis diagnostic test: Sputum smear microscopyInterventions**Intervention: Outreach clinics and health promotion**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, health workers conducted monthly outreach clinics in each kebele.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, health promoters visited houses, distributed leaflets and posters, and promoted messages at schools and public gatherings.Were health workers trained in tuberculosis diagnosis? Yes, 4 days training on case finding, diagnostic procedures, handling of sputum.\
**Group 2**\
No interventionOutcomes**Outcomes included in the review**\
Additional tuberculosis cases detectedTuberculosis treatment completionDefaultTuberculosis mortalityNotesCountry: Ethiopia\
Setting: Rural districts\
Tuberculosis prevalence: Not stated\
HIV prevalence: Not stated\
Study dates: 1 May 2003 to 30 April 2004\
Study sponsor: The Centre for International Health, University of Bergen***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskComment: Described as \"randomised\"; no further details given.Allocation concealment (selection bias)Unclear riskComment: Not described, but usually low risk in cluster‐randomized trials if the sequence generation is low risk.Blinding of participants and personnel (performance bias) All outcomesLow riskComment: None described, but unlikely to bias the results of the trial.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: None described.Incomplete outcome data (attrition bias) All outcomesLow riskComment: No loss of clusters. No other losses described.Selective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Similar characteristics (low risk)\
Loss of clusters: None (low risk)\
Incorrect analysis: Primary outcome adjusted for clustering.\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0016]MethodsTrial design: Cluster‐RCT\
Unit of randomization: Microscopy centres\
Number of clusters per study group: 18\
Length of follow‐up: 12 months\
Adjusted for cluster design: Not describedParticipantsTarget group: Children aged less than 14 years\
Total population of study areas: Not stated\
Total number of people screened for tuberculosis in intervention area: 1943\
Exclusions: None stated.\
Tuberculosis screening test: None described.\
Tuberculosis diagnostic test: Keith Edwards tuberculosis scoreInterventions**Intervention: Training of health staff and health promotion**\
Did health workers look for tuberculosis cases outside of health facilities? No.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, health education sessions using flip charts, posters and pamphlets at tuberculosis clubs, village doctor meetings, girl guide and boy scout meetings.Were health workers trained in tuberculosis diagnosis? Yes, health workers were trained to weigh children, assess severe malnutrition, perform the Mantoux test, and use the Keith Edwards Child Tuberculosis score chart.\
**Control**\
No interventionOutcomes**Outcomes included in the review**\
Additional tuberculosis casesNotesCountry: Bangladesh\
Setting: Unclear\
Tuberculosis prevalence: 207 per 100,000 adults\
HIV prevalence: Not reported\
Study dates: 2007 to 2009\
Study sponsor: Damien Foundation Bangladesh***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"One intervention centre was randomly selected from each district, and two from the larger districts containing more than the median number of centres. A similar number of control microscopy centres were selected in the same districts\"Allocation concealment (selection bias)Unclear riskComment: Not described, but usually low risk for cluster‐randomized trials if the random sequence is low risk.Blinding of participants and personnel (performance bias) All outcomesLow riskComment: No blinding of participants or health workers described, but this is unlikely to bias the results separate from the effects of the intervention.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: None described.Incomplete outcome data (attrition bias) All outcomesLow riskComment: No loss of clusters occurred. No other losses reported.Selective reporting (reporting bias)Low riskComment: No evidence of selective reporting.Other biasLow riskRecruitment bias: Low risk\
Baseline imbalance: Similar characteristics (low risk)\
Loss of clusters: None (low risk)\
Incorrect analysis: Primary outcome not adjusted for clustering, Cochrane Review adjusts for this (low risk).\
Comparability with RCTs randomizing individuals: Unclear risk[@CD011432-bbs2-0017]MethodsTrial design: Non‐RCT\
Intervention area: Sidima zone, Southern Ethiopia\
Control area: Hadiya zone, Southern Ethiopia\
Length of follow‐up: 14 monthsParticipantsTarget group: All ages\
Total population of intervention area: Over 3 million\
Total number of people screened for tuberculosis in intervention area: Not stated\
Exclusions: None stated.\
Tuberculosis screening test: Symptom screen: cough \> 2 weeks\
Tuberculosis diagnostic test: Sputum smear microscopyInterventions**Intervention areas: Training of health extension workers to visit houses and screen for tuberculosis**\
Did health workers look for tuberculosis cases outside of health facilities? Yes, health extension workers went house to house using a symptom screen.Were there health promotion activities to encourage people with symptoms to attend health services? Yes, community meetings, campaigns, and local radio.Were health workers trained in tuberculosis diagnosis? Yes, health extension workers were trained to screen for chronic cough and collect, store, and transport sputum samples.Additional activities: Awareness creation workshops for political, community, and religious leaders, teachers and other stakeholders. Improvement in laboratory services, and supervision of health extension workers.\
**Control areas: No intervention**\
Health extension workers did not receive training, but provided health services including health education about tuberculosis to people in their kebeles.Outcomes**Outcomes included in the review**\
Additional tuberculosis casesTuberculosis cureTreatment completionEarly default (prior to commencing treatment or during the intensive phase of treatment)Tuberculosis mortalityNotesCountry: Ethiopia\
Setting: Community based\
Tuberculosis prevalence: 127 per 100,000 population\
HIV prevalence: Not stated\
Study dates: October 2010 to December 2011\
Study sponsor: TB REACH Initiative of the Stop TB Partnership (through a grant from the Canadian International Development Agency)***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskComment: Not randomizedAllocation concealment (selection bias)High riskComment: Not randomizedBlinding of participants and personnel (performance bias) All outcomesLow riskComment: Health workers and populations were not blind to the allocation, but this was unlikely to bias the effect of the intervention.Blinding of outcome assessment (detection bias) All outcomesHigh riskComment: No blinding of outcome assessorsIncomplete outcome data (attrition bias) All outcomesUnclear riskComment: The number of lost or invalid sputum smears was not reported.Selective reporting (reporting bias)Low riskComment: No evidence of selective reportingOther biasLow risk**[ROBINS‐I bias domains]{.ul}**\
Confounding: Minimal confounding (moderate risk)\
Selection of participants: All study participants were included (low risk).\
Classification of interventions: Intervention status is well defined (low risk).\
Deviations from intended interventions: None expected (low risk).\
Missing data: None (low risk)\
Measurement of outcomes: Comparable between groups (low risk)\
Selection of reported results: None (low risk)[^14]

Characteristics of excluded studies \[ordered by study ID\] {#CD011432-sec2-0020}
===========================================================

StudyReason for exclusion[@CD011432-bbs2-0018]No community‐level interventions[@CD011432-bbs2-0019]No community‐level interventions[@CD011432-bbs2-0020]No parallel control group[@CD011432-bbs2-0021]No parallel control group[@CD011432-bbs2-0022]No parallel control group reported. A control area is described, but TB outcomes are only reported for the area with the intervention.[@CD011432-bbs2-0023]No intervention to increase TB diagnosis[@CD011432-bbs2-0024]No parallel control group[@CD011432-bbs2-0025]Intervention not at the primary care level. No parallel control group.[@CD011432-bbs2-0026]No intervention to increase TB diagnosis[@CD011432-bbs2-0027]No parallel control group[@CD011432-bbs2-0028]No intervention to increase TB diagnosis[@CD011432-bbs2-0029]No parallel control group[@CD011432-bbs2-0030]No community‐level interventions. This study was conducted among gold mine workers, not the general population.[@CD011432-bbs2-0031]No community‐level intervention[@CD011432-bbs2-0032]No parallel control group[@CD011432-bbs2-0033]No parallel control group[@CD011432-bbs2-0034]No community‐level interventions[@CD011432-bbs2-0035]No community‐level interventions[@CD011432-bbs2-0036]No parallel control group[@CD011432-bbs2-0037]No parallel control group[@CD011432-bbs2-0038]No parallel control group[@CD011432-bbs2-0039]No parallel control group[@CD011432-bbs2-0040]No parallel control group[@CD011432-bbs2-0041]No parallel control group[@CD011432-bbs2-0042]No parallel control group[@CD011432-bbs2-0043]No parallel control group[@CD011432-bbs2-0044]No parallel control group[@CD011432-bbs2-0045]No parallel control group[@CD011432-bbs2-0046]Done in low‐burden settings[@CD011432-bbs2-0047]No community‐level intervention[@CD011432-bbs2-0048]No parallel control group. This paper describes 51 individual projects that aimed to detect TB cases. However, none of these projects had parallel control groups, and instead were compared with routinely collected data from the year before.[@CD011432-bbs2-0049]No parallel control group[@CD011432-bbs2-0050]No parallel control group[@CD011432-bbs2-0051]No parallel control group[@CD011432-bbs2-0052]No intervention to increase TB diagnosis[@CD011432-bbs2-0053]No parallel control group[@CD011432-bbs2-0054]No parallel control group[@CD011432-bbs2-0055]No parallel control group[@CD011432-bbs2-0056]No parallel control group[@CD011432-bbs2-0057]No parallel control group[@CD011432-bbs2-0058]Not a TB case‐finding study[@CD011432-bbs2-0059]Not a relevent comparison. This study screened intravenous drug users participating in a methadone substitution programme for TB. It then compares active referral with passive referral. Study does not compare a TB case‐finding intervention with no intervention.[@CD011432-bbs2-0060]No parallel control group[@CD011432-bbs2-0061]No parallel control group[@CD011432-bbs2-0062]No parallel control group[@CD011432-bbs2-0063]Not a relevent comparison. This study compares the prevalence of TB in houses with a TB contact and houses without a TB contact. It does not compare a TB case‐finding intervention with no intervention.[@CD011432-bbs2-0064]No parallel control group[@CD011432-bbs2-0065]No parallel control group[@CD011432-bbs2-0066]No parallel control group[@CD011432-bbs2-0067]No parallel control group[@CD011432-bbs2-0068]No parallel control group[@CD011432-bbs2-0069]No outcomes relevent to this review[@CD011432-bbs2-0070]No community‐level intervention. This study was done in smokers.[@CD011432-bbs2-0071]No parallel control group[@CD011432-bbs2-0072]No parallel control group[@CD011432-bbs2-0073]No parallel control group

Characteristics of studies awaiting assessment \[ordered by study ID\] {#CD011432-sec2-0021}
======================================================================

[@CD011432-bbs2-0074]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated[@CD011432-bbs2-0075]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated[@CD011432-bbs2-0076]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated[@CD011432-bbs2-0077]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated[@CD011432-bbs2-0078]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated[@CD011432-bbs2-0079]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated[@CD011432-bbs2-0080]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated[@CD011432-bbs2-0081]MethodsNot statedParticipantsNot statedInterventionsNot statedOutcomesNot statedNotesNot stated

All review authors jointly developed the protocol and provided comments and feedback. FM, AM, and DS performed data extraction and analysis, and all authors wrote the manuscript. All authors agreed on the content of the final review and its submission for publication.
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[^1]: Editorial Group: Cochrane Infectious Diseases Group.

[^2]: ^1^No serious risk of bias: the studies were generally at low risk of bias. Not downgraded. ^2^No serious indirectness. The studies were done in high‐prevalent tuberculosis settings in Africa (3) and Asia (1). The results could be generalized to other countries with similar tuberculosis burden and socioeconomic profile. ^3^Downgraded once for serious inconsistency. One study done in South Africa showed that the intervention detected fewer tuberculosis cases compared to no intervention. This cluster‐RCT had fewer participants recruited from the farmers, who may have a different risk profile compared to the general population and different from the other three cluster‐RCTs. However, in a prespecified subgroup analysis by background tuberculosis endemicity in studies conducted in areas with a prevalence of 5% or more, heterogeneity was explained and the estimate became more precise (RR 1.52, 95% CI 1.10 to 2.09, 3 trials, 155,918 participants, *moderate‐certainty evidence*). ^4^Downgraded once for serious imprecision. The 95% CI includes both clinically important effects and no difference for the effect of the intervention compared to control. ^5^Downgraded twice for serious imprecision. The 95% CI is wide and includes both clinically important effects and no difference for the effect of the intervention compared to control. The imprecision of the results could be due to small numbers of tuberculosis patients and number of tuberculosis patients with the outcome of interest. The studies were not powered enough to detect a difference between groups for the tuberculosis treatment outcomes. ^6^Downgraded once for serious imprecision. The 95% CI includes no difference for the effect of the intervention compared to the control group. The imprecision of the results could be due to small numbers of tuberculosis patients and number of tuberculosis patients with the outcome of interest. ^7^Downgraded twice for serious imprecision. ^8^Downgraded once for serious indirectness. The intervention arms had additional staff and procedures for following up patients on treatment. This may have a paradoxical effect of detecting more people who have treatment failure.

[^3]: ^1^No serious risk of bias: only one study is included and it warrants no downgrading. ^2^No serious inconsistency; it is the only cluster‐randomized trial. ^3^Downgraded twice for serious indirectness: this is a single study from Zambia and South Africa, with prevalence measured at four years. It does not exclude the possibility of effects in different settings, or at later time points. ^4^Downgraded once for serious imprecision: the 95% CI is wide and includes both clinically important effects and no difference.

[^4]: ^1^No serious risk of bias: only one study is included and it warrants no downgrading. ^2^No serious inconsistency; it is the only cluster‐randomized trial. ^3^Downgraded twice for serious indirectness: this is a single study from South Africa. ^4^No serious imprecision.

[^5]: ^1^No serious risk of bias: only one study is included and it warrants no downgrading. ^2^No serious inconsistency; it is the only cluster‐randomized trial. ^3^Downgraded twice for serious indirectness: this is a single study from Brazil. ^4^No serious imprecision.

[^6]: ^1^No serious risk of bias: only one study is included and it warrants no downgrading. ^2^No serious inconsistency; it is only cluster‐randomized trial. ^3^Downgraded twice for serious indirectness: this is a single study from Zimbabwe. It does not exclude the possibility of effects in different settings, or at later time points. ^4^No serious imprecision.

[^7]: ^1^[@CD011432-bbs2-0004]: the use of household visits is not explicitly described in the original paper. The frequency of visits was confirmed by personal communication with the author.

    Abbreviations: ART: antiretroviral therapy; CBAS: controlled before‐and‐after study; NRT: non‐randomized trial; NTP: national tuberculosis control programme; RCT: randomized controlled trial.

[^8]: ^1^The tuberculosis case notification rate (CNR) was calculated by dividing the total number of tuberculosis cases by the duration of the trial (in years), then dividing by the population of the intervention area and multiplying by 100,000.

    Abbreviations: CNR: case notification rate; CXR: chest X‐ray.

[^9]: Abbreviations: CI: confidence interval; ICC: intraclass correlation coefficient; NA: not applicable; RCT: randomized controlled trial.

[^10]: Abbreviations: CI: confidence interval; NA: not applicable; RCT: randomized controlled trial

[^11]: Abbreviations: CI: confidence interval; RCT: randomized controlled trial.

[^12]: Abbreviations: RCT: randomized controlled trial.

[^13]: Abbreviations: CI: confidence interval; NA: not applicable; RCT: randomized controlled trial.

[^14]: Abbreviations: AFB: acid‐fast bacilli; ART: antiretroviral therapy; BCG: bacille Calmette‐Guerin; CXR: chest X‐ray; PPD: purified protein derivative; RCT: randomized controlled trial; TB: tuberculosis.
